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I. INTRODUCTION
For more than six decades, most Americans have accessed
health care through employment-based health insurance. Since the
1960s, large employers have provided long-term employees with re-
tiree benefits, and prescription drug coverage has been a standard
feature for both active and retiree plans.1 The development and en-
trenched nature of the employment-based system in the United
States confounds simple explanation, but various arguments may be
advanced both in favor and against continuing the current structure
for active employees. Similar arguments apply to evaluating em-
ployment-based retiree health benefits although the presence of the
Medicare safety net fundamentally affects that analysis for Medi-
care-eligible retirees. Historically, retiree prescription drug cover-
age occupied a unique place in the discussion of employment-based
retiree benefits because Medicare excluded coverage for almost all
prescription drug costs. 2 The passage of the Medicare Prescription
Drug, Improvement, and Modernization Act of 2003 (MMA)3 com-
pletely reshaped the discussion for employment-based retiree pre-
scription drug plans by introducing primary prescription drug
coverage for all Medicare-eligible beneficiaries through a new Medi-
care Part D beginning January 1, 2006.4 This fundamental change in
Medicare raises significant questions for employers currently pro-
viding retiree prescription drug coverage as to whether they should
continue such coverage in the Part D era.
This Article (1) provides background on the development and
decline of employer-provided health insurance, with emphasis on
retiree health insurance and prescription drug coverage, including
an outline of key considerations in whether to continue the employ-
I See discussion infra Sections II.A, C & E.
2 For an overview of Medicare and prescription drug coverage, see generally Thomas R. Oli-
ver et al., A Political History of Medicare and Prescription Drug Coverage, 82 MILBANK Q. 283
(2004), available at http://www.kff.org/medicare/loader.cfm?url=/comnonspot/secur-
ity/getfile.cfm&PageID=42275 (last visited Feb. 25, 2006).
3 Medicare Prescription Drug, Improvement, and Modernization Act of 2003, Pub. L. No.
108-173, 117 Stat. 2066 (2003) [hereinafter Medicare Prescription Drug, Improvement, and
Modernization Act].
4 See id.
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ment-based system; (2) highlights the prescription drug challenge
for the elderly in this country; (3) summarizes key features for em-
ployers of the MMA's prescription drug provisions; (4) reviews cer-
tain guidance issued by the Centers for Medicare & Medicaid
Services (CMS) since passage of the MMA with respect to options
for employer-sponsored retiree prescription drug coverage; (5) sum-
marizes general employer reactions to the options; and (6) ends with
an evaluation of how the MMA changes the analysis of whether to
continue employment-based retiree prescription drug coverage after
January 1, 2006. Although this evaluation generally concludes that
public policy supports maintaining employer retiree prescription
drug coverage and that the best choice for most employers in 2006-
continuing existing plans and applying for the Medicare Part D em-
ployer subsidy--dovetails with the public policy argument, the Ar-
ticle also acknowledges that employer decisions after 2006 may well
diverge from what public policy would suggest.
II. BACKGROUND
A. Development of the Employer-Sponsored Health Insurance
System
American health insurance as it exists today has its origins in
the late 1920s when a Dallas businessman laid the foundation for
the Blue Cross organization by arranging for 1300 school teachers to
pay for twenty-one days of future hospital care through small
monthly payments to Baylor University Hospital. 5 At about the
same time, lumber and mining employers in the Pacific Northwest
established what would become the Blue Shield system by arrang-
ing with local physicians to provide care for injured workers in re-
turn for a monthly fee from the employers.6 In the 1930s, President
Franklin Roosevelt focused Social Security away from the issue of
government-funded health benefits to sidestep political conflict
with physicians,7 pushing health insurance completely into the pri-
vate sector for the next thirty years. By 1939, nonprofit Blue Cross/
Blue Shield plans offered limited hospital insurance coverage to
5 BLUECROSS BLUESH1ELD ASS'N, BLUE BEGINNINGS, http://www.bcbs.com/history/blue
beginnings.html (last visited Feb. 25, 2006).
6 Id.
7 Charles P. Hall, Jr., The Environment of Health Plans in the 1990s, in THE HANDBOOK OF
EMPLOYEE BENEFrYs 75, 79-80 (Jerry S. Rosenbloom ed., 4th ed. 1996). See also COLIN
GORDON, DEAD ON ARRIVAL: THE PoLrrcs OF HEALTH CARE 1N TWENTrIETH-CENTURy
AMERICA 217 (2003).
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three million Americans.8 A few commercial insurers offered simi-
larly limited benefits.9 For example, Aetna began offering group
health policies in 1936.10 Cigna entered the market in 1937.11
Following the attack on Pearl Harbor and the United States'
entry into World War II, Congress imposed wage and salary caps to
control escalating labor costs. 12 Non-cash fringe benefits were ex-
empted from the caps, however, allowing employers to use benefits
such as health insurance as a way of attracting and retaining em-
ployees in a tight labor market.13 By the end of World War II, em-
ployer-provided benefits had become commonplace, and employees
had grown to expect such packages as part of their overall compen-
sation.14 After a number of administrative rulings and court cases in
the mid-1940s confirmed that welfare benefits were subject to com-
pulsory collective bargaining,'5 unions began to advocate forcefully
for the expansion of employer-provided benefits for their mem-
bers. 16 In the late 1940s, President Truman pushed briefly for a na-
tional health insurance program similar to those in other industrial
nations,' 7 but employer-provided health insurance turned out to be
entrenched.' 8 In 1950, the International Union, United Automobile,
Aerospace and Agricultural Implement Workers of America (UAW)
negotiated the first employer-paid health insurance program for
members of its collective bargaining units at General Motors.19 By
8 BLUECROSS BLUESHIELD ASS'N, CoVERING AMERICA, http://www.bcbs.com/history/cover-
ingamerica.html (last visited Feb. 25, 2006).
9 Hall, supra note 7, at 80.
10 AETNA, AETNA HISTORY, http://www.aetna.com/history (last visited Feb. 25, 2006).
11 CIGNA, COMPANY HISTORY, http://www.cigna.com/general/about/history.html (last vis-
ited Feb. 25, 2006).
12 Hall, supra note 7, at 80; BLUECRoss BLUESIELD Ass'N, TIMELINE: 1940s, http://www.bcbs.
com/history/timeline40.html (last visited Feb. 25, 2006).
13 Id.
14 Hall, supra note 7, at 80.
15 See, e.g., U.S. v. United Mine Workers, 330 U.S. 258 (1947); Inland Steel Co. v. NLRB, 170 F.
2d 247 (7th Cir. 1948).
16 Hall, supra note 7, at 90.
17 CTRS. FOR MEDICARE & MEDICAID SERVS. (CMS), HISTORY, http://www.cms.hhs.gov/
about/history/cormingappa.asp (last visited Feb. 25, 2006).
18 Hall, supra note 7, at 81.
19 Mike Hudson, Soaring Big 3 Health Costs Set Up Standoff. UAW Resolves to Keep Generous
Benefits, DETROIT NEWS, July 28, 2003, at 1A.
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1951, enrollment in the Blue Cross/Blue Shield plans reached sixty
million.20
Favorable tax treatment for employer-provided benefits also
helped strengthen the position of health insurance as a standard em-
ployee benefit.21 Based on earlier wartime rulings by the Internal
Revenue Service, the Internal Revenue Code of 1954 established that
employer contributions to certain accident and health benefit plans
for employees did not constitute taxable income to the employees. 22
That exclusion continues today23-a tax subsidy (technically re-
ferred to as a "tax expenditure") estimated at $9.6 billion in 1980,24
$106.72 billion in 2004,25 and predicted to reach $150.3 billion by
2009.26
By the mid-1950s, almost seventy percent of Americans had
private health insurance coverage. 27 The 1965 enactment of Medi-
care provided coverage for Americans aged sixty-five or older, but
did not change the private employment-based system for younger
Americans. 28 Some commentators in the early 1970s hoped that the
passage of Medicare for retirees presaged the development of com-
prehensive national health insurance,29 but this proved a false hope.
Setting aside what by then constituted more than three decades of
employee expectations of employment-based health insurance, the
20 Jon R. Gabel, Job-Based Health Insurance, 1977-1998: The Accidental System Under Scrutiny, 18
HEALTH AFF., Nov.-Dec. 1999, at 62, 63, available at http://content.healthaffairs.org (last
visited Feb. 25, 2006).
21 LEONARD E. BURMAN & JONATHAN GRUBER, URBAN-BROoImNGs TAx POL'Y CTR., TAX CRED-
rTs FOR HEALTH INSURANCE (June 2005), http://www.taxpolicycenter.org/UploadedPDF/
311189_IssuesOptions_1l.pdf (last visited Feb. 25, 2006).
22 Melissa Thomasson, Health Insurance in the United States, http://www.eh.net/encyclope-
dia/?article=thomasson.insurance.health.us (last visited Feb. 25, 2006).
2 26 U.S.C. § 106 (2005).
24 The Effect of the Tax Laws on Health Insurance and Medical Costs: Hearing Before the H. Sub-
comm. on Oversight of the H. Comm. on Ways and Means and the Task Force on Tax Expenditures
of the H. Comm. on the Budget, 96th Cong. 1 (1979) (statement by Alice M. Rivlin, Director,
Cong. Budget Office, available at http://www.cbo.gov/ftpdocs/52xx/doc5228/doc25.pdf
(last visited Feb. 25, 2006).
25 EMw. BENEFIT RES. INsT. (EBRI), TAX EXPENDrrUREs AND EMPLOYEE BENEFIrs: AN UPDATE
FROM THE FY 2005 BuDcET (Feb. 2004), http://www.ebri.org/pdf/publications/facts/
0204fact.pdf (last visited Feb. 25, 2006).
2 6 Id.
27 BLuECROSS BLUESHIELD Ass'N, TIMELINE: 1950s, http://www.bcbs.com/history/timeline
50.html (last visited Feb. 25, 2006).
28 The Social Security Act limits eligibility for Medicare to those age sixty-five and older and
a few limited other categories of individuals. Social Security Act § 1811, 42 U.S.C. § 1395c
(2005).
29 Hall, supra note 7, at 83.
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national consciousness did not perceive health insurance expenses
in the early 1970s as a pressing problem for employers.30 In 1977,
82.7% of employees were eligible for coverage from their em-
ployer.31 President Carter proposed a national health plan in 1979,32
but the idea quickly died.
Health care costs rose rapidly in the 1980s, leading to the intro-
duction of managed care by mid-decade as employers struggled to
continue providing insurance and control expenses.33 By 1987, as
health care costs continued to increase, 72.4% of American workers
were eligible for employment-based health insurance. 34 President
Clinton made universal national health care a top priority in the
1990s,35 but the proposal failed. In 2001, even after a decade of
widely publicized declines in employer coverage, 74% of all adults
ages thirty-five to fifty-four and 66% of adults ages fifty-five to
sixty-four still enjoyed employer-provided health insurance. 36 A
2003 survey indicated that the percentage of U.S. employers offering
health benefits has remained relatively constant since 1996, from
59% in 1996 up to 69% in 2000 and down to 66% in 2003.37 By 2005,
with a struggling economy and constantly increasing health care
costs, the percentage had dropped to 60%.38 In general, larger firms
30 See Michael S. Gordon, Introduction to the Second Edition: ERISA in the 21st Century in EM-
PLOYEE BENEFITS LAW, at lxiii (Steven J. Sacher et al. eds., 2d ed. 2000).
31 Gabel, supra note 20, at 66.
32 President James Carter, National Health Plan - Remarks Announcing Proposed Legisla-
tion (June 12, 1979), available at http://www.cms.hhs.gov/about/history/presidents/
Carter 6 12279.asp (last visited Feb. 25, 2006).
3 Frontline: The High Price of Health (PBS television broadcast Apr. 14, 1998) (summary of
Uwe Reinhardt, Managed-Care Industry in Perspective (1998), http://www.pbs.org/wgbh/
pages/frontline/shows/hmo/procon/hoperspective.html (last visited Feb. 25, 2006)).
34 Gabel, supra note 20, at 66.
35 President William Clinton, Address to a Joint Session of the Congress on Health Care
Reform (Sept. 22, 1993), available at http://63.241.27.78/about/history/presidents/Clin-
ton9_22_93.asp (last visited Feb. 25, 2006).
36 The Future of Retiree Health Benefits: Challenges and Options: Hearing Before the Subcomm. on
Employer-Employee Relations of the H. Comm. on Educ. & the Workforce, 106th Cong. (2001)
(statement of Patricia Neuman, Vice President & Director, Medicare Pol'y Project, Henry J.
Kaiser Fain. Found.), available at http://www.kff.org/medicare/6010-index.cfm (last vis-
ited Feb. 25, 2006) [hereinafter Future of Retiree Health Benefits].
37 HENRY J. KAIsER FAM. FOUND. AND HEALTH RES. & EDUC. TRUST, EMPLOYER HEALTH BENE-
Frrs: 2003 ANNUAL SURVEy 40 (2003), available at http://www.kff.org/insurance/loader.
cfm?url=/commonspot/security/getfile.cfm&Pageld=20672 (last visited Feb. 25, 2006)
[hereinafter KAISER/HRET 2003 SURVEY].
38 HENRY J. KAISER FAM. FouND. AND HEALTH RES. & EDUC. TRUST, EMPLOYER HEALTH BENE-
Frrs: 2005 ANNUAL SURVEY 14 (2005), available at http://www.kff.org/insurance/7315/sec-
tions/upload/7375.pdf (last visited Feb. 25, 2006) [hereinafter KASER/HRET 2005
SURVEY].
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are more likely to offer health coverage to employees.39 In 2004,
99% of all firms with more than 200 employees offered some form of
health benefits, as compared to 87% of companies with twenty-five
to forty-nine employees, 74% of companies with ten to twenty-four
employees, and only 52% of companies with three to nine employ-
ees.40 In 2005, 98% of firms with 200 or more employees and 59% of
firms with three to 199 workers offered some form of health
benefits.41
B. Evaluating the Employer-Sponsored Health Insurance
System
After almost seven decades of employer-sponsored health in-
surance coverage as the norm for American society, commentators
sometimes refer to the arrangement as an "accidental" system,42
with all the idiosyncrasies and inconsistencies such terminology im-
plies. Whether aptly so described or not, advocates of creating some
form of government-managed universal health care typically do not
analyze whether the employment-based system makes sense to
maintain independently. 43 Instead, they focus on the problems fac-
ing those not covered by employer-provided health insurance and
present health care as a basic right that should be guaranteed to all
Americans. 44 For example, observing that the "greatest gap in our
social security structure is the lack of adequate provision for the Na-
tion's health" and characterizing health as fundamental to American
"ideals of freedom and equality," President Truman in his 1948 State
of the Union address noted that "most of our people cannot afford
to pay for the care they need" and argued for a national health in-
surance system that would provide coverage to all citizens equally.45
More than thirty years later, President Carter in 1979 similarly de-
scribed access to health care as "a basic right for Americans," and
focused on the need for a national health plan to protect individuals
39 See id.; HENRY J. KAtsER FAM. FOUND. AND HEALTH REs. & EDUC. TRUST, EMPLOYER HEALTH
BENEFrIs: 2004 SUMMARY OF FINDINGS 5 (2004), available at http://www.kff.org/insurance
/7148/loader.cfm?url=/commonspot/security/getfile.cfm&pageID=46287 (last visited
Feb. 25, 2006) [hereinafter KAISER/HRET 2004 SUMMARY].
40 KAISER/HRET 2004 SUMMARY, supra note 39, at 5.
41 KAISER/HRET 2005 SURVEY, supra note 38, at 13.
42 See, e.g., Gabel, supra note 20.
43 See, e.g., Clinton, supra note 35.
44 See, e.g., id.
45 President Harry Truman, State of the Union Address (Jan. 7, 1948), available at http://
www. thisnation.com/library/sotu/1948ht.html (last visited Feb. 25, 2006).
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from the risk of financial ruin due to catastrophic illness as well as
to provide comprehensive coverage to approximately at sixteen mil-
lion low-income uninsured Americans. 46 A similar conception of
health care as a fundamental right for Americans permeated Presi-
dent Clinton's 1993 universal health care proposal-what he pro-
claimed as "our most urgent priority, giving every American health
security, health care that can never be taken away, health care that is
always there. '47 These pronouncements of health care as a basic
right of all individuals implicitly reject treating health care as a priv-
ilege of economic and employment status, yet stop short of calling
for the dismantling of the existing employment-based system. In
any case, for a variety of political, social and economic reasons that
lie well beyond the scope of this Article, all federal proposals for
universal health care to date have been doomed while the employ-
ment-based system continues to lumber along.
This Article assumes that universal access to health care in the
United States at least qualifies as a preferred social goal, if not a
basic human right. This Article does not assume that the employ-
ment-based system necessarily provides the best mechanism for
achieving that social goal. However, with regard to the limited
question of how best to provide retiree prescription drug coverage
in the post-MMA era, this Article does evaluate the employment-
based system on the basis of a relatively narrow field of competing
factors. These factors are discussed broadly in the remainder of this
Section.
At least one historian has recently grouped explanations of the
absence of a national American health care system into three com-
peting theories: (1) American "popular or cultural faith in private
solutions and a corresponding distrust of 'radical' political solu-
tions," (2) structural bias in American political systems against
strong national political institutions and, by extension, against com-
prehensive reform on a national level, and (3) class politics that pro-
mote economic interests and disregard the working populace. 4
Each of these, if valid, might argue in favor of the employment-
based system. For example, to the extent Americans pride them-
selves on individualism and private solutions to problems, private
enterprise would inherently seem the preferred mechanism for pro-
viding health insurance. Similarly, if a bias against government so-
46 Carter, supra note 32.
47 Clinton, supra note 35.
48 Gordon, supra note 30, at 3-7.
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lutions agitates against national health insurance, in the absence of
effective state regulation,49 private employers may stand next in line
as the logical institutions to inherit responsibility for health insur-
ance coverage. Finally, if American culture does in fact glorify eco-
nomic power over all else, with employers as the natural
beneficiaries of that ideology, leaving the employment-based sys-
tem alone may be the natural result of an overall value system en-
trenched in American society.
Other arguments in favor of the employment-based system
also exist. For example, as long as the private sector continues to
provide health insurance benefits to a significant portion of the pop-
ulace, the government escapes financial responsibility for health
care for the covered individuals. One may argue, of course, that in
the absence of any universal government-funded health care sys-
tem, the government is not actually saving money because it would
not currently shoulder the cost of health care for most individuals in
any case. This argument, however, seems disingenuous because in-
dividuals without health insurance still need health care and even-
tually will find their way into the public health charity care system
if they have no other alternatives. At that point, their health care
expenses do become taxpayer-funded. The more individuals who
enjoy health insurance coverage through their employers, the fewer
individuals will need such last-resort charity care, and this limits on
a societal level the need for government expenditures for such care.
Another argument in favor of the employment-based system
comes out of insurance principles. To the extent that any solution to
providing health care involves an insurance-based system,5° em-
ployer groups avoid adverse selection issues because they "exist[ ]
for reasons other than the purchase of insurance."51 In the absence
of a government program that forces everyone into a risk pool, indi-
vidual health insurance or even group health insurance programs
for groups that have banded together solely because of a perceived
need for health insurance create the classic adverse selection risk
that insurers cannot afford to enable: The only people who will buy
49 
It should be noted that state power to regulate employee benefits, including health insur-
ance, is extremely limited due to the preemptive impact of the Employee Retirement In-
come Security Act of 1974 ("ERISA"), which effectively exempts a self-insured employer
plan from virtually all state regulation. 29 U.S.C. § 1144(a) (2000).
50 Most major health care reform proposals have assumed that any long-term solution to
achieving at least widespread access to health care will involve some type of insurance-
based arrangements. See, e.g., Truman, supra note 45; Clinton, supra note 35.
51
INST. OF MED., EMPLOYMENT AND HEALTH BENEFrrs: A CONNECTION AT RISK 67 (Marilyn J.
Field & Harold T. Shapiro, eds., 1993) [hereinafter EMPLOYMENT AND HEALTH BENEFrs].
94 Hous. J. HEALTH L. & POL'Y
insurance will be the ones who most need it. Employer programs,
especially ones that cover all employees, naturally spread the risks
across a broader range of people and bring healthy individuals into
the pool who will pay (or have paid on their behalf) premiums in
excess of what those healthy individuals will cost, offsetting the ex-
penses of those who become ill and cost more than they contributed.
As compared to individual purchasers of health insurance, em-
ployers-particularly large ones-also have the benefit of lever-
age.52 Being able to negotiate with insurance companies from a
position of economic strength means that an employer will typically
be able to purchase insurance at a lower rate than an individual
would be charged for the same product. Although a government
health insurance program would obviously have even greater lever-
age, in the absence of such a program, employers may be the entities
with the greatest bargaining strength and thus the greatest ability to
obtain reasonably priced health insurance for large numbers of indi-
viduals. Admittedly, small employers may not enjoy much more
bargaining strength than individuals, and, to the extent that the
populace is employed more by small employers than large, the
value of leverage may be limited in its application.
Retaining the employment-based health insurance system may
also promote creativity and flexibility. Particularly in the absence of
significant government regulation in this field, each employer can
negotiate its own terms and conditions, and can develop innovative
cost-control strategies. 53 For example, managed care in the late
1980s and early 1990s developed in large part out of large employ-
ers' efforts to control skyrocketing costs. 54 Although legitimate ar-
guments may exist that employer cost control efforts, including
managed care, do not always advance the quality of health care pro-
vided, anything that might rein in health care costs in the United
States deserves some level of positive consideration.
Beyond cost control, the creativity and flexibility allowed by
the employment-based system may actually serve certain groups of
the population better than any one-size-fits-all national system
would. An individual employer may tailor coverage to meet the
needs of that employer's workforce in a way that no broad-based
system could.5 5 Such targeted coverage may well be more cost-ef-
52 Id. at 9.
53 Id. at 9-10.
54 See Reinhardt, supra note 33.
55 EMPLOYMENT AND HEALTH BENEFITS, supra note 51, at 10.
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fective because it may allocate premium dollars where they are truly
needed rather than paying for certain types of coverage that are less
important to a particular population.
Somewhat separate from the societal policy question of
whether employers are objectively the best source of health insur-
ance coverage for the working population is the question of why
employers might choose to provide coverage for their own reasons.
Currently, many employers may feel they have no other choice in
light of employee expectations. 56 After decades of coverage, for an
employer to not provide coverage might simply be unacceptable to
their employees. For an employer with many similarly-situated
competitors in a particular industry, virtually all of whom offer
health insurance benefits to employees, 5 7 to fail to offer such benefits
could place an employer at a distinct competitive disadvantage in
recruiting and retaining qualified workers. Moreover, employers
may perceive that employees remain healthier, more productive,
and less likely to miss work due to sickness when employees have
access to quality health care through an employer-sponsored health
insurance benefit plan. In fact, employers increasingly have recog-
nized that preventive health programs tend to lower overall health
care costs. 58 Some employers may also be motivated simply by a
paternalistic desire to protect and care for their employees.
Arguments rooted in fairness and equality tend to lie on the
other side of both the societal benefits of continuing employment-
based health insurance coverage and the reasons individual em-
ployers might want to provide such benefits. For example, although
making health insurance primarily available through employment-
based groups may avoid adverse selection on some levels, it also
may encourage employers to select employees in part based on a
perception of health.59 After all, because employers shoulder much
of the cost of the employment-based risk pools, employers want the
healthiest-generally least expensive-employees in those pools.6°
56 See discussion supra Section H.A regarding the development of employee expectations of
employment-based health insurance.
57 See KAiFSR/HRET 2004 SumMARY, supra note 39, at Exhibit G.
'8 See, e.g., Julie Appleby, Companies Step up Wellness Efforts, USA TODAY, July 31, 2005, at 1A.
-9 The Americans with Disabilities Act attempts to limit the degree to which employers may
make hiring decisions based on health factors. See, e.g., 42 U.S.C. § 12112(a) (2005). The
Health Insurance Portability and Accountability Act also bars employer group health
plans from basing eligibility to enroll in a group health plan on any one of a number of
health-related factors. 29 U.S.C. § 1182(a)(1) (2002).
60 See, e.g., Steven Greenhouse & Michael Barbaro, Wal-Mart Memo Suggests Ways to Cut Em-
ployee Benefit Costs, N.Y. TiMEs, Oct. 26, 2005, at Cl.
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Because people who are seriously ill may also simply be too sick to
be in the workforce, a natural self-selection of healthier people into
employment-based health insurance may also exist. Moreover, em-
ployers may design benefits to avoid providing certain types of cov-
erage that may be most needed by the sickest individuals.61 Federal
law generally does not mandate coverage of any particular type of
benefit; employers retain tremendous latitude to carve out certain
types of coverage.62 The very creativity and flexibility that may be
touted as a positive attribute of the employment-based system
means that some employers may make choices that do not further
overall societal goals of caring for the ill.
The employment-based system also does nothing for the un-
employed. Although low unemployment presumably ranks with
broad access to health care as a general societal goal, universal em-
ployment probably cannot occur, if for no other reason than individ-
uals eventually age and most cannot continue working indefinitely.
An employment-based health care system simply cannot meet the
needs of an entire population. Even the leverage that employers en-
joy in purchasing reduced-cost health insurance most likely benefits
only larger employers. Not surprisingly, the percentage of employ-
ers offering health insurance drops precipitously as the size of the
employer decreases. 63
In addition, a loudly lamented challenge of the employment-
based system is its cost-both actual premium expenses and related
administrative burdens.64 Expecting employers to shoulder the fi-
nancial burden for a perceived basic social need places employers in
an unenviable financial position. Even employers who are provid-
ing health care benefits not merely due to a sense of historical or
competitive necessity, but also out of a sincere concern for employee
welfare, may find that health care costs threaten the viability of their
businesses. As health care costs have increased, employers have in-
creasingly struggled with providing employment-based health in-
surance benefits,65 constantly searching for ways to reduce and
control costs. In the past decade or so, this search has often targeted
retiree health benefits, as discussed in the next two Sections.
61 EMPLOYMENT AND HEALTH BENEFITS, supra note 51, at 9.
62 See discussion of ERISA's preemption impact, supra note 49.
63 See KAISER/HRET 2004 SutmARY, supra note 39, at 5.
64 See, e.g., Saul Friedman, The Crumbling Obstacle to Universal Health Care, NEWSDAY, Nov. 26,
2005, at B6.
65 Cynthia Harrington, Health Care Costs on the Rise, J. oF ACCT., May 2003, http://www.
aicpa.org/pubs/jofa/may2003/harring.htm (last visited Feb. 25, 2006).
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C. Development of Employer-Sponsored Retiree Health
Insurance
In the days before health care expenses dominated national
news, and as employer-provided health insurance became common-
place for employees in the 1950s and 1960s, unions began to push
employers to continue that insurance into retirement. 6 With health
insurance costs relatively low, employers often viewed retiree
health insurance as an easy bargaining chip to offer in union negoti-
ations.67 Still, by the 1960s, only 56% of Americans over age sixty-
five enjoyed any form of health insurance,6 employer-provided or
otherwise. In 1962, only 21% of Americans age sixty-five or older
had employer-sponsored health insurance coverage.69 The limita-
tions of the system became evident as the first retirees under the
Social Security Act began to leave employment and found them-
selves unable to obtain affordable private medical insurance. 70
Eventually, Congress responded to the crisis by enacting Medicare
in 1965 as Title XVIII of the Social Security Act.71
After the passage of Medicare, retiree health insurance, at least
for Medicare-eligible retirees, tended to be fairly inexpensive as it
provided primarily supplemental coverage to wrap around Medi-
care's generous benefits72-with the glaring exception of prescrip-
tion drug coverage, which generally was not provided by
Medicare.73 There were relatively few retirees as compared to the
active population, and retirees often simply remained on the active
plans.74 Retiree medical plans also began to expand in the late 1960s
66 PATRICIA H. BORN & ALIcE M. ZAWACK, U.S. CENSUS BUREAU, MANUFACTURING FIRMS'
DECISIONS REGARDING RETIREE HEALTH INSURANCE (June 2003), available at http://www.
ces.census.gov/paper.php?paper=101680 (last visited Feb. 25, 2006).
67 U.S. GEN. ACCT. OFFICE, RETIREE HEALTH PLANS: HEALTH BENEFrrS NOT SECURE UNDER
EMPLOYER-BASED SYSTEM, Report No. GAO/HRD-93-125 (July 1993), available at http://
www.gao.gov/cgi-bin/getrpt?HRD-93-125 (last visited Feb. 25, 2006) [hereinafter RETIREE
HEALTH PLANS].
68 Lynn Bailey, An American Healthcare Primer, THE S.C. NURSE, Oct.-Dec. 2003, http://www.
findartides.com/p/articles/mi qa4lO3/is 200310/ai-n9306384 (last visited Feb. 25, 2006).
69 ROLAND D. McDEvITr ET AL., WATSON WYATr WORLDWIDE, RETIREE HEALTH BENEFrrs: TnE
TO RESUSCITATE? 3 (2002), http://www.americanbenefitscouncil.org/documents/w559.
pdf (last visited Feb. 25, 2006).
70 Hall, supra note 7, at 82.
71 Id. See also Oliver et al., supra note 2, at 290-91. Title XVIII of the Social Security Act is
codified beginning at 42 U.S.C. § 1395.
72 McDEvrrr ET AL., supra note 69, at 3.
73 See discussion infra Section II.E.
74 McDEvrrr ET AL., supra note 69, at 3.
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due in part to the passage of the Age Discrimination in Employment
Act in 1967 and other age discrimination prohibitions.75 Employers
found it safer to encourage older workers to retire by offering gener-
ous retirement packages, including retiree medical coverage, rather
than risk the possibility of litigation over involuntary terminations.76
Passage of the Employee Retirement Income Security Act of 1974
gave employers more design flexibility by generally exempting self-
insured plans from state regulation. 77 Retirement coverage for pre-
Medicare retirees expanded even further in the recession years of
the 1970s and 1980s as employers enhanced early retirement pro-
grams to induce voluntary retirement, both to shrink workforces
through attrition in difficult economic environments and to open
positions for large numbers of baby boomers entering the
workforce. 78 By the late 1980s, the majority of mid-size to large em-
ployers-including 66% of firms with 200 or more employees-of-
fered some form of retiree health insurance. 79
However, despite a robust economy in the late 1980s and
1990s, the number of retiree medical plans dropped significantly. 8°
The most significant drop came between 1988 and 1991, when there
was a 20% decline in retiree health benefits offered by large employ-
ers (those with 200 or more employees).8 1 The percentage of large
employers offering retiree health benefits to retirees over age sixty-
five then declined from 80% in 1991 to only 66% in 1999.82 A 1999
survey of large employers found that 29% were "seriously consider-
ing" completely terminating retiree health coverage, 36% were con-
sidering cutting back on drug coverage, 51% were considering
shifting to a defined contribution approach, and fully 83% were con-
sidering increasing costs to retirees.83 In fact, over the following two
years, 53% of all companies offering retiree health benefits increased
75 Id.
76Id,
77 Id.; see also discussion of ERISA preemption, supra note 49.
78 MCDEVrT ET AL., supra note 69, at 4.
79 
HENRY J. KAISER FAM. FOUND., HEALTH RES. & EDUC. TRUST, & THE COMMONWEALTH FUND,
ERoSION OF PRIVATE HEALTH INSURANCE COVERAGE FOR RErREEs: FtNDiNGs FROM THE 2000
AND 2001 RETIREE HEALTH AND PRESCRItbON DRUG COVERAGE SURVEY, figs. 1 & 2 (Apr.
2002), available at http://www.kff.org/insurance/loader.cfm?url=/commonspot/secur-
ity/getfile.cfm&PageID=14152 (last visited Feb. 25,2006) [hereinafter KAISER/HRET 2000/
2001 SURVEY].
80 Future of Retiree Health Benefits, supra note 36.
81 KAISER/HRET 2003 SURVEY, supra note 37, at Exhibit 11.1.
82 Future of Retiree Health Benefits, supra note 36, at Exhibit 12.
83 Id. at Exhibit 13.
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retiree premiums. 84 Commentators at that time blamed the decline
in the overall percentage of companies who sponsored retiree health
plans on a combination of rising health care costs and the slowing
economy, as well as on the fact that new companies typically were
not implementing retiree programs in the first place.8 5 Prognosti-
cators in 2001 predicted continuing decline in employer-sponsored
retiree plans due to both "rising health care costs and the downturn
of the economy."86
By 2003, the downward trend overall for companies employing
200 or more people resulted in only 38% of such companies offering
retiree health benefits in that year.87 By 2004, the percentage again
slipped slightly downward, this time to 36%,88 but studies sug-
gested that the downward trend might be ending: A 2004 study of
large employers found that, while they might consider eliminating
subsidized retiree benefits for new hires (and, in fact, 8% had al-
ready eliminated subsidized retiree benefits for future retirees hired
after specified dates), 89 there was "virtually no interest" in terminat-
ing benefits for current retirees, and only 11% considered them-
selves "somewhat" or "very likely" to terminate subsidized benefits
for future retirees. 90 On the other hand, by 2005, the numbers had
slipped again. Only 33% of large firms offered health benefits to
both active workers and retirees in 2005.91 Moreover, in 2003, retiree
contributions for new retirees at least age sixty-five in the largest
retiree plans of employers with at least 1,000 employees increased
on average by 24%, to an average premium for retiree-only coverage
of $262 per month.92 In 2004, 19% of employers with 1,000 or more
employees required payment by retirees sixty-five years or older of
100% of the premium cost; only 11% did not require retiree pre-
mium payments.93 Furthermore, an overwhelming majority of large
84 KAISER/HRET 2000/2001 SURVEY, supra note 79, at fig. 10.
85 Future of Retiree Health Benefits, supra note 36, at 5.
8 KAISER/HRET 2000/2001 SURVEY, supra note 79, at iv.
8" KAISER/HRET 2003 SURVEY, supra note 37, at Exhibit 11.1.
m KAISER/HRET 2004 SumMARy, supra note 39, at 5.
89 HENRY J. KAISER FaM. FOUND. & HEwrrT Assoc., CURRENT TRENDS AND FUTURE OUTLOOK
FOR RETIREE HEALTH BENEFITS: FINDINGS FROM THE KAISER/HEWITr 2004 SURVEY ON RETIREE
HEALTH BENEFITS, Exhibit 27 (Dec. 2004), available at http://www.kff.org/medicare/7194/
loader.cfm?url=/commonspot/security/getfile.cfm&PageId=49752 (last visited Feb. 25,
2006) [hereinafter KAISER/HEWTrr 2004 SURVEY FINDINGS].
90 Id. at Exhibit 23.
91 KAIsER/HRET 2005 SURVEY, supra note 38, at 18.
92 KAISER/HEWITT 2004 SURVEY FINDINGS, supra note 89, at Exhibit 10.
93 Id. at Exhibit 12.
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employers in 2004 considered themselves likely to make some sort
of change to retiree health benefits that would increase the premium
or other cost-sharing obligation for retirees. 94
In recent years, companies that continue to offer retiree health
insurance tend to be larger. In 2003, only 10% of firms with fewer
than 200 employees offered retiree health benefits, 32% of those
with 200 to 999 employees offered such benefits, 48% of those with
1,000 to 4,999 employees provided retiree health insurance, and 54%
of those with 5,000 or more employees provided retiree coverage.95
Looking at the numbers from the beneficiary perspective, in 2003, of
Medicare-eligible retirees with supplemental health benefits, 9%
had worked for firms with fewer than 200 employees, 8% had
worked for employers with 200 to 999 employees, 18% had worked
for firms with 1,000 to 4,999 employees, and 65% retired from firms
with 5,000 or more employees.9 6 The availability of retiree health
insurance also reflects an employer's unionized status. In 2003, 56%
of firms with 200 or more employees who offered retiree health in-
surance were unionized. 97
D. Evaluating Employer-Sponsored Retiree Health Insurance
While the statistics in the preceding Section reveal a similar
pattern to active employee health insurance coverage, in that larger
employers tend to provide both active and retiree coverage far more
than smaller employers, 9 employer-provided retiree health insur-
ance clearly operates in a different environment than active em-
ployee health insurance. The fact that 98% of large employers in
2005 provided health insurance to active employees, 99 but only 33%
of such large employers in the same year also offered retiree health
insurance, 100 strongly suggests that employers do not perceive active
employee and retiree populations the same. To some degree, this
94 
Id. at 35. Overall, 13% were considering shifting to a defined contribution approach, 18%
were considering a shift to requiring retirees to pay 100% of the costs (and the employers
were, in effect, merely providing access to health insurance), 51% thought they were
"somewhat" or "very likely" to increase co-insurance or co-payments by retirees, and 85%
anticipated being "somewhat" or "very likely" to increase retiree premium contributions.
Id. at Exhibits 27 and 28.
95 KAISER/HRET 2003 SURVEY, supra note 37, at Exhibit 11.2.
96 KAiSER/HRET 2000/2001 SURVEY, supra note 79, at fig. 4.
97 KAISER/HRET 2003 SURVEY, supra note 37, at Exhibit 11.5.
98 KAISER/HRET 2004 SuMMARY, supra note 39, at 5.
99 KAISER/HRET 2005 SURVEY, supra note 38, at 13.
100 Id. at 18.
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may reflect less entrenched assumptions about employer responsi-
bilities toward retirees than toward active employees. After all, re-
tiree health insurance developed later than employer-provided
insurance for active workers and, even in its infancy in the 1950s
and 1960s, tended to be viewed as a relatively minor expense. 10' De-
spite the later expansion of retiree health benefits, retiree health in-
surance never reached the pervasiveness of insurance for active
employees, and the costs were historically dramatically lower, at
least for Medicare-eligible retirees. 10 2 On the government side, the
enactment of Medicare suggests that American society has some-
how classified the elderly in a different category than the rest of the
populace and that, whatever the arguments as to whether universal
access to health care for those under age sixty-five qualifies as a ba-
sic right or a preferred social goal, access to health care for the eld-
erly is, in fact, a right in the United States-with the exception of
prescription drug coverage before 2006. Medicare's passage also
suggests that, if the social need is sufficiently pressing, American
society can occasionally move beyond its ordinary preference for
private solutions.
Taking into account the fundamentally different background
that exists for retiree health benefits as a result of Medicare, evaluat-
ing the employment-based system for retiree health insurance based
on the same factors applied earlier to active health insurance 0 3
should logically result in different conclusions. On the other hand,
many of the general policy arguments in favor of maintaining em-
ployer-based retiree health insurance coverage resemble the argu-
ments in favor of such coverage for active employees. For example,
the more individuals covered by employment-based coverage, the
fewer individuals are likely to need government-funded care. Retir-
ees who are not eligible for Medicare (typically, early retirees who
have not yet attained the age of sixty-five) appear indistinguishable
from active employees with regard to the need for health insurance
in that neither qualifies for a government-based safety net.I°4 For
Medicare-eligible retirees, however, employer health insurance-
with the notable exception of retiree prescription drug coverage pre-
101 McDEvrrr ET AL., supra note 69, at 3.
102 Id.
103 See supra Section 1113.
104 See id. for a discussion of the absence of a government-managed universal health care
system in the United States. See also Future of Retiree Health Benefits, supra note 36, at Ex-
hibit 13.
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MMA-typically merely supplements Medicare, 105 and thus hardly
would seem to relieve the government of any significant financial
cost. To the extent that employer coverage provides greater pre-
ventative care, or that individuals may access health care more read-
ily if they have employer coverage, perhaps employment-based
retiree health benefits stave off more serious-and more expen-
sive-health care problems and thus indirectly reduce the burden
on Medicare. Such expense reduction for taxpayers may seem re-
mote, however, in the context of Medicare-eligible retirees.
For retirees who are not yet eligible for Medicare, the issues are
different. Losing employer coverage can be devastating, not dissim-
ilar from the crisis that faces any uninsured individual in American
society with health care needs, except that retirees may face a partic-
ularly daunting job market if they try to find new employment with
health care coverage. 10 6 Many early retirees can neither afford to
buy private insurance, if any is available-which it often is not if a
retiree has any health problems-nor afford to pay for care di-
rectly,10 7 yet they may not qualify for Medicaid. As a result, it is for
the early retirees that the arguments for maintaining employer-
sponsored benefits seem most urgent. Employers apparently recog-
nize this distinction, providing retiree health benefits more often to
pre-Medicare retirees than to those eligible for Medicare. 10 8 For ex-
ample, in 2005, among employers with 200 or more employees who
offered retiree health insurance, 94% provided such coverage for re-
tirees who were not yet Medicare eligible, but only 81% provided
such coverage for Medicare-eligible retirees. 0 9
From the insurance perspective, the fact that retirees' raison
d'etre as a separate health insurance risk pool is their prior employ-
ment relationship, not their need for health insurance, helps avoid
adverse selection just as with active employee risk pools and with-
out regard to whether individuals qualify for Medicare. Similarly,
to the extent that an employer enjoys leverage in negotiating insur-
ance rates (and acknowledging the limits of this leverage for smaller
105 McDEvrr-r ET AL., supra note 69, at 3.
106 Future of Retiree Health Benefits, supra note 36, at Exhibit 13.
107 Id. at 2-4.
108 KAISER/HRET 2000/2001 SURVEY, supra note 79, at fig. 2.
109 KAISER/HRET 2005 SURVEY, supra note 38, at 19. These statistics have remained relatively
constant. In 1999, 93% of larger employers (200 or more employees) offering retiree health
benefits offered the benefits to pre-Medicare retirees as compared to 76% of such employ-
ers making the same offer to Medicare-eligible retirees. KAISER/HRET 2003 SURVEY, supra
note 37, at Exhibit 11.3.
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employers), that benefit applies equally to retiree (Medicare-eligible
and otherwise) and active employee groups. The value of innova-
tive cost-control strategies and flexible benefit design also applies to
all employer-sponsored programs although employers may be more
willing to apply more drastic cost-control techniques to retiree
groups, especially Medicare-eligible groups for which the govern-
ment has provided a significant health care safety net that does not
exist for other groups. For example, almost all firms offering retiree
health insurance also impose significant service requirements for an
employee to qualify for the benefits. 10 In 2001, firms with 3 to 199
employees on average required at least 13 years of service; firms
with 200 or more employees on average required at least 10 years of
service."' Similarly, employers typically require a higher level of
cost-sharing from retirees than from employees. 12 For example, in
2001, retiree premiums tended to be $20 per month more than pre-
miums for active employees of the same company, and on average
retirees with employer coverage tended to pay at least 26% of the
overall premium costs as opposed to only 13% for active employ-
ees. 113 Finally, to whatever degree employers experience altruistic
concern for employee welfare, that paternalism should in theory ex-
tend to retirees as well as to current employees. However, employ-
ers may feel fewer obligations with regard to Medicare-eligible
groups because of the Medicare safety net.
Significant differences in the analysis, however, do apply. Not
only does employer-provided retiree health insurance occupy a
weaker historical position than active employee health benefits, but
two of the key motivating factors for employers in providing health
insurance for employees largely vanish when the discussion shifts
to retirees. First, employers do not compete against other employ-
ers for retirees, which means that the need to maintain competitive
benefits commensurate with other similar employers does not exist.
Although active employees may consider retiree benefit packages in
making employment decisions, such long-term considerations may
rank below other types of compensation, especially for younger
110 KAISER/HRET 2000/2001 SuRVEY, supra note 79, at fig. 3.
111 Id. These statistics reflect a dramatic increase from 1984 when only about 10% of compa-
nies offering retiree health insurance required more than five years of service for eligibil-
ity. Christian E. Weller & Jeffrey Wenger, The Interaction between Health, Health Insurance
and Retirement, at 7, http://www.nd.edu/-tghilard/Weller%20paper.htm (last visited
Feb. 25, 2006); McDETr ET AL., supra note 69, at 15.
112 KAISER/HRET 2000/2001 SuRvEY, supra note 79, at fig. 6.
113 Id.
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workers. If older workers dominate a workforce, employers may
perceive that terminating or reducing retiree health insurance
would severely damage employee morale and retention, but such
concern tends to be a feature of workplaces only in economic
booms, not in times of economic uncertainty. Second, protecting
employee health as a means to enhance productivity and reduce ab-
senteeism obviously does not extend to retirees who, by definition,
no longer contribute actively to the workplace. Without these two
significant offsetting benefits for employers, the chief burden of
maintaining retiree health insurance-the cost-may easily out-
weigh any general employer sense of obligation or paternalistic con-
cern, particularly with regard to Medicare-eligible retirees.
The fact that retiree health insurance tends to be extremely ex-
pensive1 4 tips the scale even farther against an employer's main-
taining retiree health benefits. For example, retiree health expenses
in 2004 represented 29% of the total health care expense for large
employers providing coverage to actives, retirees, and depen-
dents. 5 Moreover, the accounting treatment for retiree health in-
surance expenses makes them a particularly visible cost because
Financial Accounting Standard (FAS) 106, "Employers' Accounting
for Postretirement Benefits Other Than Pensions," requires employ-
ers to reflect the present value of future postretirement benefit liabil-
ity on their current financial statements." 6 In fact, commentators
have generally blamed FAS 106, which became effective in 1993, for
the dramatic drop in the number of retiree health insurance plans in
the early 1990s.117 Even when large employers have not actually ter-
minated retiree plans, in the wake of FAS 106 liability disclosure,
many employers with at least 1,000 employees have reacted to ris-
ing costs and reporting obligations by capping their future retiree
medical expenditures." 8 Capping these expenses means that, once
114 Retiree health insurance costs have been attributed to a variety of factors, including the
rising cost of medical care, the shifting ratio of retired to active workers, a trend of early
retirement before Medicare eligibility, and Medicare's own cost control measures (which
shift more cost to employer plans). See Stephen R. Miller et al., Postretirement Medical Bene-
fits Plans: An Analysis of Funding and Termination Issues, 12 J. PENSION PLAN & COMPLIANCE
193, 193-94 (1986).
115 Ild.
116 McDsvrrr ET AL., supra note 69, at 10.
117 Future of Retiree Health Benefits, supra note 36, at 5.
11 A 2004 survey found that 54% of large firms surveyed had capped their contributions for
retiree health care. KAISER/HEwrT 2004 SuRvEy, supra note 76, at 9-11. The same survey
found that, among firms with a cap on retiree health expenses, not only had 89% capped
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medical costs rise above a certain level, retirees assume the cost
burden.
Other employer-specific factors may also affect an employer's
decision as to whether to maintain retiree health insurance. For ex-
ample, many employers still have union contracts that require re-
tiree health benefits," 9 and it is unlikely that unions will relinquish
this benefit in the foreseeable future. A number of large employers
in 2004 noted that retiree health insurance had become "a focal
point" in union negotiations and that retiree health expenses had
been blamed as partially responsible for some company bankruptcy
filings.120 Some employers may otherwise be contractually bound to
continue retiree health benefits, at least for current retirees.
The above discussion regarding general employment-based re-
tiree health insurance applies equally to employer-sponsored retiree
prescription drug coverage, with the key difference that, before
2006, the Medicare safety net simply did not exist for prescription
drug expenses. 121 The following Sections delve into how this dis-
tinction may change the analysis for employers.
E. Development of Employer-Sponsored Retiree Prescription
Drug Coverage
In the mid-1960s, just as today, prescription drug costs posed a
serious problem, representing almost 10% of national health spend-
ing, 122 but relatively few private health insurance plans covered
such costs, especially for retirees. 123 When plans did offer prescrip-
tion drug coverage, employers imposed so many limits (co-insur-
ance, high deductibles, and low maximums) that the coverage
provided little assistance. 24 Despite these problems, cost concerns
and the political wrangling over Medicare led to its enactment with-
out any form of outpatient prescription drug coverage.25
expenses for their largest retiree health plan for those age sixty-five or older, but 56% had
already reached the cap and 27% expected to reach the cap within one to three years. Id.
119 KAISER/HRET 2003 SuRVEy, supra note 37, at Exhibit 11.5.
120 KAISER/HEWLTr 2004 SURVEY, supra note 76, at V.
121 See generally Oliver et al., supra note 2.
122 Id. at 291.
123 Id. at 293.
124 Id.
125 Id. at 294; Stephen H. Long, Prescription Drugs and the Elderly: Issues and Options, HEALTH
AFF., Supplement 1994, at 157, 158, available at http://content.healthaffairs.org/cgi/re-
print/13/2/157.pdf (last visited Feb. 25, 2006).
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The Big Three automakers (General Motors, Chrysler, and
Ford) introduced prescription drug plan coverage for union em-
ployees represented by the UAW in 1967.126 By the late 1970s, most
employer health insurance plans covered prescription drugs at
some level. 27 However, such coverage typically fell under the ma-
jor medical plan benefit and was not separately identified. 128 As a
result, prescription drug benefits tended to be subject to the same
deductibles and co-insurance as applied to general medical care.1 29
By 1987, 92% of Medicare-aged individuals with employer-spon-
sored health insurance had retiree prescription drug coverage. 130
According to a 2001 survey, virtually all individuals with employer-
sponsored retiree medical insurance received some level of prescrip-
tion drug coverage through their former employer.' 3' In 2004, 98%
of employer-sponsored retiree health plans provided prescription
drug benefits. 3 2 Overall, approximately one in three Medicare ben-
eficiaries in 2004 enjoyed prescription drug coverage through an
employer-sponsored retiree health plan. 33
Most employers in 2004 provided the drug benefit as part of
the overall retiree health plan although about 5% had created a
stand-alone prescription drug plan for retirees 34 Of retiree plans in
2004 with the largest number of Medicare-eligible retirees, 58% sub-
jected prescription drug benefits to the overall deductible and out-
of-pocket spending limits applicable to medical benefits under the
plan in general. 35 Another 27% set a separate annual drug deducti-
ble, ranging from $25 to $250 per year, with $50 being the most com-
mon drug deductible.136 Also in 2004, of the plans with the largest
number of Medicare-eligible retirees, 18% imposed separate annual
out-of-pocket maximums for pharmacy claims, with such maxi-
126 See Hudson, supra note 19.
127 Robert N. Frurnkin, Health Insurance Trends in Cost Control and Coverage, MONTHLY LAB.
REV., Sept. 1986, at 3, 7, available at http://www.bls.gov/opub/mlr/1986/09/artlfull.pdf
(last visited Feb. 25, 2006).
128 U.S. DEP'T HEALTH & HUMAN SERVS., REPORT TO THE PRESIDENT: PRESCRIPTION DRUG Cov-
ERAGE, SPENDING, UTTLIZATION, AND PRICES 11 (Apr. 2000), available at http://aspe.hhs.
gov/health/reports/drugstudy/Cl.pdf (last visited Feb. 25, 2006).
129 Id.
130 Long, supra note 125, at 160-61.
131 KAisER/HRET 2000/2001 SURVEY, supra note 79, at fig. 7.
132 KAISER/HEWITr 2004 SURVEY FINDINGS, supra note 89, at 27.
133 Id.
134 Id.
135 Id.
136 Id.
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mums ranging from $50 to $5,000 (and the most common limit be-
ing $1,500).137 Only 9% of such plans imposed a separate cap on
total covered drug expenses, and only 3% imposed separate pre-
scription drug insurance premiums.'38
Employer-sponsored retiree prescription drug plans typically
include a variety of cost control measures. For example, most re-
tiree health plans apply different co-payment percentages to differ-
ent types of drugs-i.e., generics, brand-name drugs without
generic substitutes, and brand-name drugs with generic substi-
tutes-to encourage use of less expensive alternatives. 139 Overall, in
2001, 52% of retiree health plans imposed at least two tiers of co-
payments for prescription drugs, with 29% subject to two tiers (one
for brand names and one for generics) and 23% subject to three tiers
(one for generics, one for brand names with generic substitutes, and
one for brand names without generic substitutes).14 By 2004, 58%
of all employees with employer-sponsored prescription drug cover-
age were subject to three-tiered cost-sharing structures, 4% had four
or more tiers, 19% had two tiers for their largest plan covering
Medicare-eligible retirees (one tier for generics, a second tier for all
others), and 19% had the same co-payment/co-insurance structure
for all types of drugs.141 Almost two-thirds (65%) of the plans cover-
ing the largest number of Medicare-eligible retirees in 2004 used
pharmacy benefit managers (PBMs) to administer the plans and
manage prescription drug costsya
Overall in 2004, of plans with a three-tiered cost structure, 68%
required co-payments (where a retiree pays a fixed flat amount per
prescription), 24% required co-insurance (where a retiree pays a
specified percentage of the cost of a prescription), and 8% required
both.143 In the same year, for plans with both a three-tiered cost
structure and a mail-order option, 85% required co-payments, 10%
required co-insurance, but only 5% required both.144 Also in 2004,
137 KAISER/HEWI-r 2004 SURVEY FINDINGS, supra note 89, at 27.
138/Id.
139 KAISER/HRET 2000/2001 SURVEY, supra note 79, at fig. 8.
140 Id.
141 HENRY J. KAISER FAM. FOUND., PRESCRIPIHON DRUG TRENDS (Oct. 2004), available at http://
www.kff.org/rxdrugs/loader.cfm?url=commonspot/security/getfile.cfm&PageID=48305
(last visited Feb. 25, 2006) [hereinafter PRESCRPTION DRUG TRENDS]; KAISER/HEWrrr 2004
SURVEY FINDINGS, supra note 89, at 28.
142 KAISER/HEWITT 2004 SURVEY FINDINGS, supra note 89, at 27.
143 Id. at 28.
144 Id. at 27.
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94% of large employer retiree health plans permitted use of either
retail pharmacies or mail order for prescriptions (21% required mail
order).145 The median co-payments for retail pharmacy drugs (for
plans with a three-tiered cost-sharing structure) ranged from $10 for
generics to $20 for brand-name drugs included on the plan's formu-
lary (preferred drug list) to $35 for brand-name drugs not on the
formulary; co-insurance rates at retail pharmacies were on average
20% for generic drugs, 25% for brand-name drugs included on the
plan's formulary, and 40% for brand-name drugs not included on
the plan's formulary. 146 Also for plans with a three-tiered cost-shar-
ing structure that permitted mail-order drugs, the median co-pay-
ments for mail-order drugs (typically a ninety-day supply) ranged
from $20 for generics to $40 for brand-name drugs included on the
plan's formulary (preferred drug list) to $70 for brand-name drugs
not on the formulary; co-insurance amounts for such mail-order
drugs tended to be the same as for retail pharmacy drug
purchases. 147
F. Evaluating Employer-Sponsored Retiree Prescription Drug
Coverage
To the extent that retiree prescription drug plans form an inte-
gral part of general retiree health insurance plans and do not exist
separately, the analysis above as to why employers should or might
wish to continue retiree health benefits generally applies equally to
retiree prescription drug benefits. 148 As noted earlier, the key histor-
ical difference lies in the fact that, from 1965 through 2005, Medicare
has not contained a general prescription drug benefit even for Medi-
care-eligible retirees even though some government-supported
forms of prescription drug coverage-namely, Medigap policies
and Medicare health maintenance organizations (HMOs)-have ex-
isted for a number of years. 149 In general, however, the coverage
offered by supplemental Medigap policies and Medicare HMOs has
rarely reached the same level as typical employer-provided cover-
age,150 and both options have proved to be problematic for retirees.
145 Id. at 28.
146 Id.
147 Id.
148 See supra Section II.D.
149 CMS, MEDICARE'S MILESTONES, Sept. 16, 2004, http://www.cms.hhs.gov/about/history/
mcaremil.asp (last visited Feb. 25, 2006).
150 Future of Retiree Health Benefits, supra note 36, at 4.
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Medicare HMOs have often been unstable financially, often pulling
out of markets and leaving enrollees without the anticipated supple-
mental benefits. 151 Medigap policies-with limited and statutorily
fixed supplemental benefit offerings-have been subject to pre-
mium increases that may have priced them out of range for many
Medicare beneficiaries. 152 Between 1999 and 2001, for example, pre-
miums for Medigap policies covering some prescription drugs rose
by more than 30%.
153
Without the Medicare safety net for outpatient prescription
drugs, a Medicare-eligible retiree may look no different than an
early retiree, other than perhaps being more likely to have signifi-
cant prescription drug needs. 154 Furthermore, the rationales for
maintaining or discontinuing employer-sponsored retiree prescrip-
tion drug coverage parallel arguments for and against employer-
provided general health insurance for retirees who are not yet
Medicare eligible. The need for prescription drug coverage, how-
ever, may be even more urgent than the need for general health in-
surance due to how individuals react to prescription drug costs
when they do not have prescription drug insurance. 55 As discussed
below in more detail, high prescription drug costs tend to result in
individuals' making cost-cutting choices that put health at risk.' 56
For example, individuals without prescription drug coverage may
delay or fail to fill prescriptions or skip dosages, exacerbating un-
derlying health issues.157 From a societal cost perspective, this ten-
dency of individuals toward noncompliance with regard to
prescription drugs means that, when such individuals eventually
are forced to seek health care, they may be more ill and expensive to
treat than they would have been had they followed prescription
drug orders as directed. 58 This potential increased cost impact on
society-in effect, a "common good" argument-may have been rel-
atively remote from an individual employer's decision as to
whether or not to maintain retiree prescription drug benefits. As a
151 Id. at 4-5.
152 Id. at 5.
153 Id.
154 See discussion infra Section III.B.
155 Id.
156 Id.
157 Medicare Program; Medicare Prescription Drug Benefit, 70 Fed. Reg. 4194, 4474 (Jan. 28,
2005) (to be codified at 42 C.F.R. pts. 400, 403, 411, 417, and 423).
158 See, e.g., UNIV. OF ARK. FOR MED. SCI., COMPLIANCE IN ELDERLY PATIENTS, http://www.
uans.edu/compliance/frmain.htm (last visited Feb. 25, 2006).
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result, its significance may easily be overlooked, but certainly its
presence might have advocated in favor of maintaining employer
coverage in the pre-MMA days.
Unfortunately, with prescription drug use increasing dramati-
cally with age and with prescription drug expenses soaring, as dis-
cussed in more detail below,159 employers weighing the immediate
costs and benefits of the coverage might easily decide against cover-
age based solely on the financial impact. In fact, retiree prescription
drug expenses may dwarf other retiree health insurance costs for
employers, tipping the scale even farther against such coverage than
might generally be the case for retiree health benefits. On the other
hand, for Medicare-eligible retirees before 2006, just as with pre-
Medicare-eligible retirees, the absence of a Medicare prescription
drug safety net has meant that employers could not rely on the gov-
ernment to provide comparable coverage for retirees. Through
2005, this absence-at least for those employers motivated by altru-
istic concern for their retirees-may have balanced the scale slightly
back in favor of maintaining prescription drug coverage. As noted
above, employers have historically recognized a greater obligation
to preserve retiree health benefits for those not yet Medicare-eligi-
ble.16° Subsequent Sections of this article address how the passage
of the MMA may change the analysis.
III. PRESCRIPTION DRUG CHALLENGE
A. Prescription Drug Expenses
In recent years, the cost of prescription drugs has been widely
publicized as a major health crisis. In the decade from 1970 to 1980,
prescription drug spending increased by an average of 8% per
year.161 Over the next decade, it increased by an average of 13% per
year. 162 Annual drug spending increases in the 1990s and early
2000s ranged from 6% from 1992 to 1993 to a 20% increase from 1998
to 1999 and 15% from 2001 to 2002.163 Overall, prescription drug
spending quadrupled between 1990 and 2002, reaching $162.4 bil-
lion in 2002.164 The continuing spending increases have been attrib-
159 See discussion infra Sections III.A & B.
160 See supra Section II.D.
161 PRESCRIPTION DRUG TRENDS, supra note 141.
162 Id.
163 Id.
164 Id.
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uted to three key factors: an increasing use of prescription drugs
(estimated as responsible for 42% of the increase in drug spending
from 1997 to 2002), a switch from older and less expensive drugs to
expensive new drugs (estimated as responsible for 34% of the in-
crease in drug spending over the same period), and an increase in
manufacturer prices (estimated as responsible for the remaining
25% of the spending increase over the period).165
In general, use of prescription drugs has been increasing per
person over the past decade: The number of prescriptions bought
between 1993 and 2003 increased from 2.0 billion to 3.4 billion (a
70% increase) while the U.S. population grew by only 13% over the
same period. 66 Meanwhile, retail prescription drug prices increased
an average of 7.4% per year from 1993 to 2003, reflecting both price
increases by drug manufacturers and consumers switching to more
expensive drugs.167 The price increases far outstripped the rate of
inflation over the same period-a mere 2.5%. 68
The trend of consumers switching to new and more expensive
drugs is generally blamed, at least in part, on a tremendous increase
in direct consumer advertising by drug manufacturers.1 69 By 2003,
the industry had increased its spending for consumer advertising to
more than eight times what it had spent on such advertising in
1995.170 The drug industry has also matched its advertising spend-
ing increases with increases in the prices of well-known brand-name
drugs: For example, in early 2005, the top-selling drug for individu-
als age fifty or older was Fosamax.1 71 Merck increased the whole-
sale price for Fosamax 4.5% during the first quarter of 2005.172 In
fact, for the first quarter of 2005, 110 of the 195 drugs most widely
used by individuals age fifty or older experienced some level of
price increases by drug manufacturers.1 73 For a typical older Ameri-
can taking three prescription drugs each day, assuming manufac-
turer cost increases are passed through in full to consumers, brand-
165 Id.
166 PRESCRIPTION DRUG TRENDS, supra note 141.
167 Id.
168 Id.
16 9 
Id.
17O Id.
171 AARP PUB. POL'Y INST., TRENDS IN MANUFACTURER PRICES OF BRAND NAME PRESCRIPTION
DRUGS USED BY OLDER AMERICANS-FIRST QUARTER 2005 UPDATE 8 (2005), http://assets.
aarp.org//rgcenter/health/ddl2ldrugprices.pdf (last visited Feb. 25, 2006).
172 Id.
173 Id. at 6.
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name prescription drugs cost on average $144.15 more at the end of
the first quarter of 2005 than a year earlier.174 For the first half of
2005, prescription drug prices on average increased 5.5%.175
Despite the price increases, between 2004 and 2013, U.S. drug
spending is expected to continue to increase somewhat more slowly,
at a rate of 10.7% per year. 176 This slowdown is anticipated because
of a combination of factors, namely "fewer new drugs being intro-
duced into the market, a reduction in direct-to-consumer advertis-
ing, the impending loss of patent protection for some leading drugs,
new cost-sharing provisions in private insurance contracts, and a
lower rate of price growth."'177 The projection does not take into ac-
count potential increases resulting from the introduction of the
Medicare Part D prescription drug benefit in 2006, which may im-
prove access and in turn increase spending again.178
B. Prescription Drugs and the Elderly
As health problems increase with age, so too does the use of
health care services./79 Adults ages sixty-five to seventy-four typi-
cally fill four times as many prescriptions as do adults younger than
age forty-five and almost twice as many as adults ages forty-five
and sixty-four. 180 This pattern assumes access to prescription drug
insurance; a 2001 study of Medicare-eligible individuals in eight
states, reflecting 42% of all U.S. adults ages sixty-five or older, found
that 35% of such individuals without prescription drug insurance
either did not fill a prescription or skipped dosages to extend an
existing prescription. 8 Of the surveyed Medicare-aged adults who
had prescription drug coverage, only 18% engaged in such behav-
ior.18 2 A 2003 survey found that 37% of uninsured individuals
(whether Medicare-eligible or not) failed to fill a prescription be-
cause of cost while only 13% of those with insurance failed to do
174 Id. at 4.
175 HENRY J. KAISER FAM. FOUND., KAISER DAILY HEALTH POLICY REPORT: PRESCRIPTION DRUG
PRICES INCREASED BY 5.5% IN FIRST HALF OF 2005, NEW RESEARCH INDICATES (Aug. 2, 2005)
http://www.kaisernetwork.org/daily-reports/print_report.cfm?DRID=31776&drcat=3
(last visited Feb. 25, 2006).
176 PRESCRIPTION DRUG TRENDS, supra note 141, at 2.
177Id.
178 Id.
179 Future of Retiree Health Benefits, supra note 36, at Exhibits 1 & 3.
180 Id. at Exhibit 4.
181 PRESCRIPTION DRUG TRENDS, supra note 141, at 2.
182 Id.
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so.183 A 2001 study found that Medicare beneficiaries with five or
more chronic conditions reported filling, on average, fifty prescrip-
tions a year if they have prescription drug coverage, but only an
average of thirty-eight prescriptions a year when they do not have
such coverage.' 4 Not surprisingly, an AARP survey found paying
for prescription drugs posed a problem for 71% of Americans over
age sixty-five, with 35% calling it a "major problem" and 36% calling
it a "minor problem. '185
Such actions as failing to fill prescriptions, skipping doses, and
similar actions-all considered "medication noncompliance"-tend
to exacerbate health problems and increase the need for additional
medical care. 186 In fact, a 2002 study indicated that medication non-
compliance often proves to be "a predictor of hospital admissions
and emergency room visits. '187 Despite such concerns, in the fall of
2001, 36% of all Medicare beneficiaries had no prescription drug
coverage. 188
The single largest source of prescription drug coverage for
Medicare beneficiaries was employer-sponsored retiree health
plans, covering more than a third of all those at least age sixty-five,
or about fourteen million individuals in 2001.189 Other traditional
sources of supplemental insurance have been Medigap policies,
Medicaid, and Medicare HMOs190 Medigap policies and Medicare
HMOs, however, have proved to be of limited value.191
IV. MMA AND PRESCRIPTION DRUG COVERAGE
Passage of the MMA fundamentally revised the contours of the
retiree prescription drug coverage issue, both for individuals and
for employers. The MMA introduces a new Medicare Part D that
183 Id.
184 Medicare Program; Medicare Prescription Drug Benefit, 70 Fed. Reg. 4194, 4474 (Jan. 28,
2005) (to be codified at 42 C.F.R. pts. 400, 403, 411, 417, and 423).
185 AARP, Rx WATCHDOG REPORT: FnLINrs THE PRESCRIPTON: WHAT ARE OwER ADuLTs
LOOKING FOR? (July 2004), http://assets.aarp.org/www.aarp.org_/articles/legislative/
watchdog_2.pdf (last visited Feb. 25, 2006).
186 Medicare Program; Medicare Prescription Drug Benefit, 70 Fed. Reg. at 4474.
187 Id.
188 PRESCRIPrION DRUG TRENDs, supra note 141, at 2.
189 KAISER/HRET 2000/2001 SURVEy, supra note 79, at iv.
190 Future of Retiree Health Benefits, supra note 36, at Exhibit 11.
191 Id. at 4-5; see also discussion supra Section H.F.
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will provide outpatient prescription drug coverage to Medicare-eli-
gible beneficiaries beginning in 2006.192
A. Medicare Part D Prescription Drug Coverage
In January 2006, Medicare beneficiaries became eligible to en-
roll in a new Medicare Part D and obtain outpatient prescription
drug coverage for an average monthly premium of less than $37. 193
Under the new Part D "standard" prescription drug coverage, en-
rolled Medicare beneficiaries will be required to pay for the first
$250 of their drug costs each year.1 94 The $250 annual deductible
will increase each year after 2006 to reflect annual increases in aver-
age spending by Part D enrollees on covered Part D drugs. 195 After
the annual deductible is satisfied, Medicare will pay 75% of an en-
rolled beneficiary's allowed drug costs from $250 to $2,250 (for
2006), with the beneficiary remaining responsible for a 25% co-pay-
ment.196 As with the annual deductible, the $2,250 initial coverage
limit will increase each year after 2006 to reflect annual increases in
average spending by Part D enrollees on covered Part D drugs.197 A
prescription drug plan sponsor (including a Medicare Advantage
organization) may apply a tiered co-payment structure (as is com-
mon in private sector plans), but such structure must result in a co-
insurance structure that is actuarially equivalent to an "average ex-
pected payment" of 25% of the drug costs above the deductible. 98
Once a beneficiary has incurred a set amount of out-of-pocket
costs (what CMS now calls "true out-of-pocket" expenses or
"TrOOP") for a year, Medicare will provide catastrophic coverage. 199
The out-of-pocket spending limit for 2006 is $3,600; for subsequent
192 See Medicare Prescription Drug, Improvement, and Modernization Act, supra note 3.
193 CMS, MEDICARE FACT SHEET: FINAL RULES IMPLEMENTING THE NEW MEDICARE LAW: A NEW
PRESCRIPTION DRUG BENEFIT FOR ALL MEDICARE BENEFICIARIES, IMPROVEMENTS TO MEDI-
CARE HEALTH PLANS AND ESTABLISHING OPTIONS FOR RETIREES (Jan. 21, 2005), http://www.
cms.hhs.gov/media/press/release.asp?Counter=1324 (last visited Feb. 25, 2006) [hereinaf-
ter FINAL RULES].
194 Social Security Act § 1860D-2(b)(1)(A), 42 U.S.C. § 1395w-102(b)(1)(A) (2005).
195 Social Security Act § 1860D-2(b)(1)(A)(ii), 42 U.S.C. § 1395w-102(b)(1)(A)(ii) (2005); Social
Security Act § 1860D-2(b)(6), 42 U.S.C. § 1395w-102(b)(6) (2005).
196 Social Security Act §§ 18601-2(b)(2)-(3), 42 U.S.C. §§ 1395w-102(b)(2)-(3) (2005).
197 Social Security Act § 1860D-2(b)(3)(A)(ii), 42 U.S.C. § 1395w-102(b)(3)(A)(ii) (2005); Social
Security Act § 1860D-2(b)(6), 42 U.S.C. § 1395w-102(b)(6) (2005).
198 Social Security Act § 1860D-2(b)(2), 42 U.S.C. § 1395w-102(b)(2) (2005).
199 CMS, ISSUE PAPER #23: BENEFICIARIES AND TRUE OUT-OF-POCKET COSTS (TROOP) (Jan. 21,
2005), http://www.cms.hhs.gov/medicareform/issuepapers/titeland2/files/issuezpa-
per_23_-_beneficiariesand-troop.pdf (last visited Feb. 25, 2006).
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years, the $3,600 will be adjusted-as with the annual deductible
and the initial coverage limit-to reflect annual increases in average
spending by Part D enrollees on covered Part D drugs. 00 Medi-
care's catastrophic coverage covers all allowed drug costs after the
beneficiary pays the greater of 5% co-insurance or a co-payment of
$2 for generics and $5 for other drugs (with the co-payments ad-
justed upward according to the same formula used to adjust the
out-of-spending limit, the annual deductible and the initial coverage
limit).20 1 In most cases for 2006, the catastrophic coverage will apply
after a beneficiary has incurred $5,100 in allowed drug costs. 20 2
In addition to the annual deductible and co-payments, benefi-
ciaries will be responsible for 100% of their drug costs from the ini-
tial coverage limit ($2,250 in 2006) until the TrOOP (out-of-pocket)
limit ($3,600 in 2006) is reached.20 3 This gap in which beneficiaries
are solely responsible for costs is generally referred to as the
"doughnut hole.' '2°4 If a beneficiary is reimbursed by private insur-
ance (including through an employer prescription drug plan) or
other similar reimbursement, the reimbursed amounts do not count
toward satisfying the deductible, nor are they considered in deter-
mining whether the beneficiary has incurred the doughnut hole
costs. 205 As a result, in order to receive the Medicare catastrophic
coverage benefit, a beneficiary generally cannot escape a significant
amount of out-of-pocket drug spending under a standard Part D
prescription drug plan. One exception to this is that funds from a
beneficiary's own health care spending account, such as a flexible
spending account or a health savings account, may be used to cover
the doughnut hole and still count as TrOOP spending for purposes
of reaching the catastrophic coverage threshold. 20 6
A prescription drug plan sponsor may provide alternative pre-
scription drug coverage as long as it provides benefits that CMS
considers at least actuarially equivalent to the standard package and
200 Social Security Act § 1860D-2(b)(4)(B)(i), 42 U.S.C. § 1395w-102(b)(4)(B)(i) (2005); Social Se-
curity Act § 1860D-2(b)(6), 42 U.S.C. § 1395w-102(b)(6) (2005).
201 Social Security Act § 1860D-2(b)(4)(A), 42 U.S.C. § 1395w-102(b)(4)(A); Social Security Act
§ 1860D-2(b)(6), 42 U.S.C. § 1395w-102(b)(6).
202 See, e.g., VOLUNTEERS IN HEALTH CARE, MEDICARE PART D: THE BASICS (Aug. 10, 2005),
http://www.rxassist.org/docs/medicare-d-basics.pdf (last visited Feb. 25, 2006) [herein-
after VOLUNTEERS].
203 Social Security Act § 1860D-2(b)(4), 42 U.S.C. § 1395w-102(b)(4) (2005).
204 VOLUNTEERS, supra note 202, at 3.
205 Social Security Act § 1860D-2(b)(4)(c)(ii), 42 U.S.C. § 1395w-102(b)(4)(c)(ii) (2005).
206 FINAL RULES, supra note 193, at 3.
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as long as CMS approves the alternative design.20 7 To satisfy the
actuarial equivalence requirement, not only must the plan provide
total coverage that is actuarially equivalent to the standard package,
but the unsubsidized portion of the alternative plan design must
also be actuarially equivalent to the unsubsidized portion of the
standard package.208 The maximum deductible under an alternative
package cannot exceed the standard package deductible, and the al-
ternative design must provide for payments of expenses up to the
standard package initial coverage limit (and above the standard
package deductible) that are at least equal to what Medicare would
pay under the standard package.209 The alternative design must
also provide the same level of catastrophic coverage as under the
standard package. 210
A prescription drug plan sponsor may also provide supple-
mental coverage as long as the sponsor maintains the basic benefit
package. 211 Supplemental coverage may take the form of (1) reduc-
tions in the annual deductible or coinsurance limit or an increase in
the initial coverage limit (or any combination of the preceding) as
long as the overall effect is to increase the actuarial value of the ben-
efit package above the actuarial value of the standard Part D pre-
scription drug package; or (2) coverage of certain drugs that would
be covered Part D drugs but for their exclusion from coverage under
the Medicaid program 212 (which excludes such drugs as fertility
drugs, drugs used for cosmetic purposes, weight loss/gain drugs,
and barbiturates).213
Covered drugs under Part D generally include all prescription
drugs that would be covered by Medicaid,214 biological products,
vaccines, insulin and medical supplies associated with the injection
of insulin.215 Drugs that are reimbursable under Medicare Part B or
that would be excluded under Medicaid do not qualify for Part D
coverage (but drugs covered under Part B will continue to be so
207 Social Security Act § 1860D-2(a)(1)(B), 42 U.S.C. § 1395w-102(a)(1)(B) (2005); Social Secur-
ity Act § 1860D-2(c), 42 U.S.C. § 1395w-102(c) (2005).
208 Social Security Act § 1860D-2(c)(1), 42 U.S.C. § 1395w-102(c)(1) (2005).
209 Social Security Act §§ 1860D-2(c)(1)-(2), 42 U.S.C. §§ 1395w-102(c)(1)-(2) (2005).
210 Social Security Act § 1860D-2(c)(3), 42 U.S.C. § 1395w-102(c)(3) (2005).
211 Social Security Act § 1860D-2(a)(2), 42 U.S.C. § 1395w-102(a)(2) (2005).
212 Social Security Act § 1860D-2(a)(2)(A), 42 U.S.C. § 1395w-102(a)(2)(A) (2005).
213 Social Security Act § 1927(d)(2), 42 U.S.C. § 1396r-8(d)(2) (2005).
214 Social Security Act § 1927(k)(2), 42 U.S.C. § 1396r-8(k)(2) (2005).
21- Social Security Act § 1860D-2(e)(1), 42 U.S.C. § 1395w-102(e)(1) (2005).
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covered). 16 Prescription drug plan sponsors may use formularies,
but must include coverage of drugs within each "therapeutic cate-
gory and class" of Part D drugs.1 7 Under either the standard pack-
age or an alternative design, beneficiaries must be offered the same
negotiated drug prices that apply to covered Part D drugs, even if
the beneficiary is paying the full cost of such drugs due to an annual
deductible or other cost-sharing obligation.218
B. Medicare Part D Low-Income Assistance
When Medicare Part D prescription drug coverage begins in
2006, Medicare will also begin to provide prescription drug pre-
mium support and cost-sharing subsidies for certain low-income
Medicare beneficiaries. 219 Three categories of low-income benefi-
ciaries will qualify for federal assistance: (1) those with incomes be-
low 150% of the federal poverty level220 and with limited assets
(below $10,000 for individuals, $20,000 for couples);221 (2) those with
incomes below 135% of the federal poverty level and with limited
assets (below $6,000 for individuals, $9,000 for couples), 222 and (3)
those eligible for full Medicaid benefits as well as Medicare (the so-
called "dual eligibles").223 For Medicare beneficiaries below 150% of
the poverty level, the MMA provides for a sliding-scale premium
that varies with income, 224 a $50 annual deductible, 225 15% coinsur-
ance up to $5,100 in total drug costs, 226 and limited co-payments af-
216 Social Security Act § 1860D-2(e)(2), 42 U.S.C. § 1395w-102(e)(2) (2005).
217 Social Security Act § 1860D-4(b)(3)(c), 42 U.S.C. § 1395w-104(b)(3)(c) (2005).
218 Social Security Act § 1860D-2(d)(1), 42 U.S.C. § 1395w-102(d)(1) (2005).
219 HENRY J. KAISER FAm. FOUND., LOW-INcoME ASSISTANCE UNDER THE MEDICARE DRUG BENE-
Fr (Sept. 2005), available at http://www.kff.org/medicare/7327.cfm (last visited Feb. 25,
2006); Social Security Act § 1860D-14, 42 U.S.C. § 1395w-114 (2005).
220 For 2005, the federal poverty level was $9,570 for an individual and $12,830 for a couple.
Annual Update of the HHS Poverty Guidelines, 70 Fed. Reg. 8373 (Dep't of Health and
Human Servs. Feb. 18, 2005) (notice); Social Security Act § 1860D-14(a), 42 U.S.C. § 1395w-
114(a) (2005).
221 CMS, ISSUE PAPER #3: ADDITIONAL HELP TO THOSE WHO NEED IT MOST: THOSE WITH HIGH
DRUG COSTS AND THOSE WITH Low INCOMES (Jan. 21, 2005), available at http://www.cms.
hhs.gov/States/Downloads/MedicarePrescriptionDrugProgram&LimitedIncomeAssis-
tance.pdf (last visited Feb. 25, 2006) [hereinafter ISSUE PAPER #3].
222 Social Security Act § 1860D-14(a)(1)(A), 42 U.S.C. § 1395w-114(a)(1)(A) (2005); IssuE PAPER
#3, supra note 221.
223 Social Security Act § 1860D-14(a)(3)(B)(v), 42 U.S.C. § 1395w-114(a)(3)(B)(v) (2005); FINAL
RULES, supra note 193 (defining "dual eligible").
224 Social Security Act § 1860D-14(a)(2)(A), 42 U.S.C. § 1395w-114(a)(2)(A) (2005).
225 Social Security Act § 1860D-14(a)(2)(B), 42 U.S.C. § 1395w-114(a)(2)(B) (2005).
226 Social Security Act § 1860D-14(a)(2)(D), 42 U.S.C. § 1395w-114(a)(2)(D) (2005).
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ter the out-of-pocket $3,600 threshold is met. 227 For Medicare
beneficiaries below 135% of the poverty level, the MMA provides
for no premium (or a reduced premium in some cases),228 no de-
ductible,229 limited co-payments up to the $3,600 out-of-pocket
threshold,230 and no co-payments once $3,600 in out-of-pocket costs
have been incurred.231 Beginning in 2006, dual eligibles are exempt
from Medicare Part D prescription drug plan premiums and de-
ductible payments232 and from any co-payment requirements after
the first $3,600 in out-of-pocket costs. 233 Special additional provi-
sions apply to dual eligibles.234
C. Medicare Part D Prescription Drug Plan Sponsor
Requirements
In general, any insurer seeking to sponsor a Medicare Part D
prescription drug plan beginning in 2006 must either satisfy the
health insurer licensing requirements of the state in which it wishes
to offer such a plan235 or qualify for a waiver of those requirements
by the Department of Health and Human Services (HHS).236 The
MMA provides two kinds of waivers. The first-a regional plan
waiver-permits HHS to waive any particular state's licensing re-
quirement for a period of time for a prescription drug plan sponsor
that is offering service to an entire region and is licensed in at least
one state in the region.237 Under the second type of waiver, HHS
must waive a state's licensure requirements if a state takes certain
actions, such as applying discriminatory criteria, or fails to act in a
timely manner.238 Even with a waiver, a Medicare prescription drug
227 Social Security Act § 1860D-14(a)(2)(E), 42 U.S.C. § 1395w-114(a)(2)(E) (2005).
228 Social Security Act § 1860D-14(a)(1)(A), 42 U.S.C. § 1395w-114(a)(1)(A) (2005).
229 Social Security Act § 1860D-14(a)(1)(B), 42 U.S.C. § 1395w-114(a)(1)(B) (2005).
230 Social Security Act § 1860D-14(a)(1)(D)(iii), 42 U.S.C. § 1395w-114(a)(1)(D)(iii) (2005).
231 Social Security Act § 1860D-14(a)(1)(E), 42 U.S.C. § 1395w-114(a)(1)(E) (2005).
232 Social Security Act §§ 1860D-14(a)(l)(A)-(B), 42 U.S.C. §§ 1395w-114(a)(1)(A)-(B) (2005).
233 Social Security Act § 1860D-14(a)(1)(E), 42 U.S.C. § 1395w-114(a)(1)(E) (2005).
234 See, e.g., Social Security Act § 1860D-14(a)(1)(D), 42 U.S.C. § 1395w-114(a)(1)(D) (2005).
235 Social Security Act § 1860D-12(a)(1), 42 U.S.C. § 1395w-112(a)(1) (2005).
236 Social Security Act § 1860D-12(a)(1), 42 U.S.C. § 1395w-112(a)(1) (2005); Social Security Act
§ 1860D-12(c), 42 U.S.C. § 1395w-112(c) (2005).
237 Social Security Act § 1860D-12(c)(1)(B), 42 U.S.C. § 1395w-112(c)(1)(B) (2005); Social Secur-
ity Act § 1858(d), 42 U.S.C. § 1395w-27a(d) (2005). The regional waiver provisions also
apply to Medicare Advantage plans. Social Security Act § 1858(d), 42 U.S.C. § 1395w-
27a(d) (2005).
238 Social Security Act § 1860D-12(c)(1), 42 U.S.C. § 1395w-112(c)(1) (2005); Social Security Act
§§ 1855(a)(2)(B)-(D), 42 U.S.C. §§ 1395w-25(a)(2)(B)-(D) (2005).
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plan sponsor must still satisfy solvency requirements established by
HHS.
239
The MMA also requires a prescription drug plan sponsor to
follow certain enrollment, disenrollment, termination and change of
enrollment rules, generally similar to those applicable to Medicare
Advantage 24° (previously Medicare+Choice) plans.241 These rules in-
clude a requirement that the plan be open only to enrollees who
reside within a geographic area served by the plan,242 detailed pro-
visions as to timing and duration of enrollment and disenrolment
elections, 243 and mandatory approval of all marketing materials by
CMS.244 Medicare prescription drug plan sponsors must also permit
Medicare beneficiaries to enroll during specified "special enrollment
periods," generally resulting from a beneficiary's involuntary loss of
"creditable prescription drug coverage" (coverage recognized as
comparable to Part D prescription drug coverage). 245
Medicare Part D prescription drug plan sponsors must not
only disclose certain information, such as negotiated prices, to CMS
in such manner as CMS determines,246 but must also provide signifi-
cant annual disclosures to enrollees.247 The annual disclosures to
enrollees must include information about access to covered drugs,
how the plan's drug formulary works (if the plan uses a formulary),
and the enrollee's cost-sharing obligations.248 Additional informa-
tion, such as general coverage information, the plan's utilization
cost control processes, and grievance and appeal statistics, which
must be provided to enrollees upon request.249 Specific information
must be available to enrollees on a "timely basis" through a toll-free
telephone number and in writing if requested. 25° Plan sponsors
must make available on an internet website any changes in plan for-
239 Social Security Act § 1860D-12(a)(3), 42 U.S.C. § 1395w-112(a)(3) (2005); Social Security Act
§§ 1860D-12(d)(1)-(2), 42 U.S.C. §§ 1395w-112(d)(1)-(2) (2005).
24 0 Social Security Act § 1860D-l(b)(1), 42 U.S.C. § 1395w-101(b)(1) (2005).
241 Medicare Prescription Drug, Improvement, and Modernization Act, supra note 3, at
§ 201(b).
242 Social Security Act § 1851(b)(1)(A), 42 U.S.C. § 1395w-21(b)(1)(A) (2005).
243 Social Security Act §§ 1851(e)-(f), 42 U.S.C. §§ 1395w-21(e)-(f) (2005).
244 Social Security Act § 1851(h), 42 U.S.C. § 1395w-21(h) (2005).
245 Social Security Act § 1860D-1(b)(3), 42 U.S.C. § 1395w-101(b)(3) (2005).
246 Social Security Act § 1860D-2(d)(2), 42 U.S.C. § 1395w-102(d)(2) (2005).
247 Social Security Act § 1860D-4(a)(1)(A), 42 U.S.C. § 1395w-104(a)(1)(A) (2005).
248 Social Security Act § 1860D-4(a)(1)(B), 42 U.S.C. § 1395w-104(a)(1)(B) (2005).
249 Social Security Act § 1860D-4(a)(2), 42 U.S.C. § 1395w-104(a)(2) (2005); Social Security Act
§ 1852(c)(2), 42 U.S.C. § 1395w-22(c)(2) (2005).
250 Social Security Act § 1860D-4(a)(3)(A), 42 U.S.C. § 1395w-104(a)(3)(A) (2005).
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mularies. 251 Plan sponsors must also provide enrollees with "easily
understandable" explanations of benefits and notices of benefits that
reflect the initial coverage limit and the out-of-pocket threshold for
the applicable year.252
Additional requirements for Part D drug plan sponsors include
a requirement that plans enlist a "sufficient number of pharmacies
... to ensure convenient access" (other than through mail order).253
Plan sponsors must also issue a drug card or "other technology"--in
accordance with standards established by CMS-to an enrollee to
"assure access" to the drug plan's negotiated prices.254 If a plan
wants to use a formulary, a number of detailed rules apply to the
development and adoption of the formulary. These rules include a
requirement that the proposed formulary be reviewed by at least
one practicing physician and one practicing pharmacist who are "in-
dependent and free of conflict" with regard to the plan sponsor and
the plan and who have "expertise in the care of elderly or disabled
persons."' 2 5 Prescription drug plan sponsors must maintain a "cost-
effective drug utilization management program"; a medication ther-
apy management program; a program to control fraud, waste, and
abuse; and "quality assurance measures and systems to reduce med-
ication errors and adverse drug interactions and improve medica-
tion use. '25 6  Plan sponsors must also "provide meaningful
procedures" for grievance resolution,257 and for claims determina-
tions and appeals. 258 Drug plan sponsors are also subject to periodic
audit by CMS to protect against fraud and abuse.259
Assuming a prescription drug plan sponsor develops a plan
that meets all of the above requirements, the sponsor must submit a
bid to CMS, including, among other information, a description of
the coverage the plan provides (including the deductible and cost-
sharing requirements), the actuarial value of the coverage, and the
service area for the plan.26° CMS will then review the bid and ap-
251 Social Security Act § 1860D-4(a)(3)(B), 42 U.S.C. § 1395w-104(a)(3)(B) (2005).
252 Social Security Act § 1860D-4(a)(4), 42 U.S.C. § 1395w-104(a)(4) (2005).
253 Social Security Act § 1860D-4(b)(1)(C), 42 U.S.C. § 1395w-104(b)(1)(C) (2005).
254 Social Security Act § 1860D-4(b)(2), 42 U.S.C. § 1395w-104(b)(2) (2005).
255 Social Security Act § 1860D-4(b)(3)(A)(ii), 42 U.S.C. § 1395w-104(b)(3)(A)(ii) (2005).
256 Social Security Act § 1860D-4(c)(1), 42 U.S.C. § 1395w-104(c)(1) (2005).
257 Social Security Act § 1860D-4(f), 42 U.S.C. § 1395w-104(f) (2005).
258 Social Security Act §§ 1860D-4(g)-(h), 42 U.S.C. §§ 1395w-104(g)-(h) (2005).
259 Social Security Act § 1860D-2(d)(3), 42 U.S.C. § 1395w-102(d)(3) (2005).
260 Social Security Act §§ 1860D-11(b)(1)-(2), 42 U.S.C. §§ 1395w-111(b)(1)-(2) (2005).
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prove or disapprove the plan.26 1 Among other factors, CMS must
consider whether the plan design is "likely to substantially discour-
age enrollment by certain part D eligible individuals .... ,262 If the
design results in such discouragement, CMS must disapprove the
bid. 263 If a bid is approved, the prescription drug plan sponsor must
then enter into a contract with CMS before the sponsor may actually
offer a Part D prescription drug plan.264
D. Medicare Advantage
In the pre-Part D era, one alternative for Medicare beneficiaries
seeking supplemental coverage, particularly prescription drug cov-
erage, was a private insurance approach, introduced in 1999 as
"Medicare+Choice" or Medicare Part C and renamed by the MMA
as "Medicare Advantage."26 Medicare Advantage plans offer at
least the same benefits as Medicare Parts A and B, but may also
offer additional benefits to entice beneficiaries. 266 Depending on the
state, Medicare Advantage plans have included both Medicare
HMOs and private fee-for-service plans under contract with Medi-
care.267 Medicare Advantage plans have generally been attractive to
Medicare beneficiaries, but financial problems have resulted in a
trend of Medicare Advantage insurers pulling out of markets across
the country.268
In addition to changing the name, the MMA made a number of
other changes intended to improve the Medicare Part C program
and expand its availability, as well as coordinating Part C programs
with the new Medicare Part D prescription drug coverage. 269 Begin-
ning in 2006, Medicare Advantage enrollees normally will receive
their prescription drug coverage through their Medicare Advantage
261 Social Security Act § 1860D-11(e)(1), 42 U.S.C. § 1395w-111(e)(1) (2005).
262 Social Security Act § 1860D-11(e)(2)(D), 42 U.S.C. § 1395w-111(e)(2)(D) (2005).
263 Id.
264 Social Security Act § 1860D-12(b)(1), 42 U.S.C. § 1395w-112(b)(1) (2005).
265 Medicare Prescription Drug, Improvement, and Modernization Act, supra note 3, at
§ 201(b).
266 42 C.F.R. §§ 422.101-102 (2003).
267 See, e.g., TEXAS DEP'T OF INS., MEDICARE ADVANTAGE PLANS FOR MEDICARE BENEFICIAlRES
(Aug. 2005), http://www.tdi.state.tx.us/consumer/cbo36.html (last visited Feb. 25, 2006).
268 See JosE MONTEMAYOR, TEXAS DEP'T OF INS., OPTIONS FOR TEXANS WHO LOSE MEDICARE
HMO COVERAGE, http://www.tdi.state.tx.us/commish/colunms/cc0999.doc (last visited
Feb. 25, 2006).
26 9 
CMS, CHOICES FOR MEDICARE ADVANTAGE (Jan. 19, 2005), http://63.241.27.78/medicarere
form/pdbma/aiandocs/issuepaper_2_-_choices_formaaian.pdf (last visited Feb. 25,
2006).
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plans.2 70 In fact, as long as the Medicare Advantage plan in which a
Medicare beneficiary is enrolled offers Part D prescription drug cov-
erage, the enrolled individual may not separately enroll in another
Part D prescription drug plan.271 If, however, a Medicare benefici-
ary is enrolled in a Medicare Advantage private fee-for-service plan
that does not include Part D prescription drug coverage, the indi-
vidual may enroll in a separate prescription drug plan for Part D
coverage. 272
Provisions of the MMA applicable to prescription drug plan
sponsors apply generally to Medicare Advantage plan sponsors that
provide prescription drug coverage to their enrollees. 273 Medicare
Advantage plan sponsors must offer prescription drug coverage
through at least one Medicare Advantage plan offered by the organ-
ization in any given area. 274
E. Medicare Part D Employer Subsidies
The MMA provides tax-free subsidies for employer-sponsored
retiree prescription drug plans offering prescription drug coverage
that is at least equal to the actuarial value of the MMA's standard
prescription drug coverage and that meets certain other require-
ments.275 During debate on the MMA, a key concern was that em-
ployer-sponsored retiree health plans might choose to reduce or
eliminate prescription drug coverage for Medicare-eligible benefi-
ciaries, accelerating the decline in employer-sponsored retiree
health benefits.276 To offset this, the MMA included employer subsi-
dies. If an employer-sponsored retiree prescription drug plan quali-
fies for the subsidy, the federal government will pay the sponsoring
employer a subsidy equal to 28% of a qualifying enrollee's allowa-
ble annual prescription drug expenses from $250 to $5,000 (indexed
after 2006), for a maximum annual subsidy of $1,330 per enrollee. 277
CMS estimates that the subsidy will average $668 per beneficiary in
270 Social Security Act § 1860D-1(a)(1)(B)(i), 42 U.S.C. § 1395w-101(a)(1)(B)(i) (2005).
271 Social Security Act § 1860D-1(a)(1)(B)(ii), 42 U.S.C. § 1395w-101(a)(1)(B)(ii) (2005).
272 Social Security Act § 1860D-l(a)(1)(B)(iii), 42 U.S.C. § 1395w-101(a)(1)(B)(iii) (2005).
273 See, e.g., Social Security Act § 1860D-41(b), 42 U.S.C. § 1395w-151(b) (2005).
274 Social Security Act § 1860D-21(a)(1), 42 U.S.C. § 1395w-131(a)(1) (2005).
275 Social Security Act § 1860D-22(a)(2), 42 U.S.C. § 1395w-132(a)(2) (2005).
276 See generally HENRY J. KAISER FAM. FoUND. & HEwITT Ass'N, RETIREE HEALTH BENEFITS
Now AND IN THE FurURE (Jan. 14, 2004), http://was4.hewitt.com/hewitt/resource/news-
room/pressrel/2004/01-14-04_report.pdf (last visited Feb. 25, 2006).
277 Social Security Act § 1860D-22(a)(3), 42 U.S.C. § 1395w-132(a)(3) (2005).
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2006.278 The subsidy is payable only with respect to retirees who are
not enrolled in Medicare Part D.279
Employer retiree health plans qualify for the MMA employer
subsidy if they provide retiree prescription drug coverage that satis-
fies the MMA subsidy requirements.28° To receive the subsidies,
employers must first ascertain whether their retiree prescription
drug plans provide coverage that is at least actuarially equivalent in
value to that provided under the standard MMA prescription drug
package.281 Most current employer-sponsored retiree prescription
drug plans are believed to provide such coverage given the typical
richness of such plans.282 However, the MMA requires an annual
attestation to HHS of such actuarial equivalence.283 The MMA also
requires that employers maintain certain records to allow CMS to
audit and provide oversight,284 and that employers notify all retir-
ees, spouses, and dependents who are eligible for the retiree pre-
scription drug plan as to whether coverage under the employee
plan constitutes "creditable coverage" under the MMA. 285 If the
coverage is not "creditable," retirees who subsequently enroll in a
Medicare Part D prescription drug plan may be subject to late en-
rollment penalties.286
Although an employer will not receive the subsidy for a retiree
who is both covered by the employer's retiree prescription drug
plan and enrolled in Medicare Part D, nothing in the MiMA prevents
such dual enrollment.28 7 In addition, nothing in the MMA prevents
an employer-sponsored retiree health plan from paying for a re-
tiree's premium under a Medicare Part D prescription drug plan,
278 Medicare Program; Medicare Prescription Drug Benefit, 70 Fed. Reg. 4194, 4478 (Jan. 28,
2005) (to be codified at 42 C.F.R. pts. 400, 403, 411, 417, and 423).
279 MARK HAMELBURG, CMS, MMA TECHNICAL ASSISTANCE: EMPLOYER AND UNION GROUP
ISSUES (May 19, 2005), http://www.healthactioncouncil.org/pdf/handouts/CMS_
MhamelburgEmployerGroup.pdf (last visited Feb. 25, 2006).
280 Social Security Act § 1860D-22(a)(2), 42 U.S.C. § 1395w-132(c)(3) (2005).
281 See, e.g., Greta E. Cowart, Employer Sponsored Group Health Plan Changes in the Medicare
Prescription Drug Improvement and Modernization Act of 2003, A.L.I.-A.B.A. 413, 420 (Sept.
8, 2005).
282 See, e.g., MELLON FIN. CORP., MELLON COMMDENTS TO CMS ON MEDICARE REGULATIONS,
HIGHLIGHTS OF OUR COMMENTS (Oct. 5,2004), http://www.mellon.com/hris/pdf/fyi_10_
05_04b.pdf (last visited Feb. 25, 2006).
283 Social Security Act § 1860D-22(a), 42 U.S.C. § 1395w-132(a) (2005).
2m Social Security Act § 1860D-22(a)(2)(B), 42 U.S.C. § 1395w-132(a)(2)(B) (2005).
285 Social Security Act § 1860D-22(a)(2)(C), 42 U.S.C. § 1395w-132(a)(2)(C) (2005).
286 Social Security Act § 1860D-13(b), 42 U.S.C. § 1395w-113(b) (2005).
287 Social Security Act § 1860D-22(a)(6), 42 U.S.C. § 1395w-132(a)(6) (2005).
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from offering coverage under the retiree plan that is better than the
standard Part D prescription drug package, or from providing sup-
plemental coverage to Part D for retirees who are not enrolled in the
employer's retiree prescription drug plan but are covered by Part
D.288 The MMA specifies that employer retiree prescription drug
plan design decisions do not need to reflect the Part D standard pre-
scription drug package, as long as the overall design meets the actu-
arial equivalence requirements of the MMA (for employers who
wish to qualify for the MMA subsidy).28 9
The MMA also permits CMS to waive certain Part D require-
ments for employer-sponsored prescription drug plans if the re-
quirements "hinder the design of, the offering of, or the enrollment
in such... plans."290 Even before the MMA, CMS had the "author-
ity to waive or modify requirements that hinder the design of, the
offering of, or the enrollment in Medicare Advantage plans by an
employer" or labor union group.291 The MMA simply extends this
authority to cover prescription drug plans under Medicare Part D. 292
The waiver authority applies to contracts between employers and
prescription drug plans or Medicare Advantage prescription drug
plans, as well as to direct contracts between CMS and employers
sponsoring their own prescription drug plans or Medicare Advan-
tage prescription drug plans.293 The waiver authority allows CMS to
authorize separate premiums for employer-sponsored retiree pre-
scription drug plans and limitations of enrollment in such plans to
the applicable employer's retirees and dependents.294
V. CMS GUIDANCE FOR EMPLOYERS ON IMPLEMENTATION
OF THE MMA
Since the passage of the MMA, CMS has issued hundreds of
pages of regulatory guidance aimed at explaining and facilitating
implementation of Part D's prescription drug coverage provi-
sions.295 Significant amounts of this guidance have focused directly
288 Id.
289 Id. at (D).
290 Social Security Act § 1860D-22(b), 42 U.S.C. § 1395w-132(b); Social Security Act § 1857(i),
42 U.S.C. § 1395w-27(i) (2005).
291 HAMELBURG, supra note 279, at 14.
292 Id. at 15.
293 Id.
294 Social Security Act § 1860D-22(b), 42 U.S.C. § 1395w-132(b) (2005).
295 See discussion infra Sections V.A & B.
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on employer issues. In fact, CMS has stated that it "intend[s] to im-
plement the drug benefit to permit and encourage a range of op-
tions for Medicare beneficiaries to augment the standard Medicare
coverage .... [ilnclud[ing] facilitating coverage through employer
plans .... 296
A. August 2004 Proposed Rule
CMS' first major piece of guidance was a 231-page Proposed
Rule issued in August 2004 that included 176 pages of comments
preceding introduction of new regulations implementing Part D
prescription drug coverage.297 CMS simultaneously issued a Pro-
posed Rule implementing the Medicare Advantage program.298 The
Part D Proposed Rule stated CMS' policy goal of "reducing incen-
tives for current employers, other insurers and government pro-
grams to reduce their current levels of coverage and replace that
coverage with Part D wrap-around benefits .. .
The Proposed Rule outlined several basic options for employ-
ers with retiree prescription drug plans. First, employers may con-
tinue to maintain their existing retiree prescription drug plan. If the
plan provides drug benefits that are at least actuarially equivalent to
the Part D standard prescription drug package, the employer will be
eligible for the Part D employer subsidy to offset the employer's
costs. 3°° CMS noted that an employer who wants to qualify for the
employer subsidy and also wants to provide retiree health insur-
ance through a Medicare Advantage program can do so by selecting
a Medicare Advantage program without a Part D drug benefit.3°1
The employer then separately designs a drug benefit that provides
coverage at least actuarially equivalent to the Part D standard drug
benefit package, thereby qualifying for the subsidy, and then offers
that coverage either directly or through a separate contract with a
Medicare Advantage organization (which offers the alternative
package as a private insurance option).3°2
296 Medicare Program; Medicare Prescription Drug Benefit, 69 Fed. Reg. 46,632, 46,633 (Aug.
3, 2004) (to be codified at 42 C.F.R. pts. 403, 411, 417, and 423).
297 Id. at 46,632-46,863.
298 Medicare Program; Establishment of the Medicare Advantage Program, 69 Fed. Reg.
46,866 (Aug. 3, 2004) (to be codified at 42 C.F.R. pts. 417 and 422).
29 Medicare Program; Medicare Prescription Drug Benefit, 69 Fed. Reg. at 46,650.
300 Id. at 46,698.
301 Id.
302 Id.
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Employers can also provide supplemental or "wrap-around"
coverage. In this model, an employer whose coverage doesn't qual-
ify for the Part D employer subsidy (because it is not sufficiently
generous as to be actuarially equivalent to the Part D standard drug
benefit package) uses the funds it previously directed toward some
level of retiree prescription drug coverage to assist retirees with Part
D costs not covered by Medicare (for example, the annual deducti-
ble and cost-sharing expenses).3 3 A similar alternative for employ-
ers is to pay all or part of the monthly Part D premium for retirees
who enroll in Part D prescription drug plans or Medicare Advan-
tage plans that include Part D prescription drug benefits.3°4
Finally, CMS suggested in the Proposed Rule that employers
may offer a Part D prescription drug plan or Medicare Advantage
prescription drug plan tailored specifically for their retirees, either
through a contract with a third-party Part D prescription drug plan
sponsor (or Medicare Advantage prescription drug plan sponsor) or
directly under a CMS waiver.3 5 In either case, the employer's costs
will be reimbursed by Medicare to the extent Medicare covers the
benefit package, just as with any other approved Part D prescription
drug plan.30
6
CMS acknowledged in its comments to the Proposed Rule that
any of the options that provide more generous benefits below the
catastrophic coverage level than the basic Part D standard package
will simply delay when Medicare's catastrophic coverage becomes
effective.307 A beneficiary still must incur the same level of out-of-
pocket expenses before Medicare's catastrophic coverage becomes
effective, no matter what the option. For a retiree with relatively
low prescription drug costs, having enhanced coverage as a result of
an employer plan that provides either enhanced alternative cover-
age or wrap-around benefits will undoubtedly put that retiree in a
better position than before Medicare Part D because the retiree's ex-
penses are subsidized by both the employer and Medicare. For a
retiree with high prescription drug costs, the retiree is certainly not
in a worse position by having the employer plan because his or her
maximum exposure is still primarily the Medicare Part D out-of-
pocket spending limit, plus the limited co-payments once Medicare
303 Id.
304 Medicare Program; Medicare Prescription Drug Benefit, 69 Fed. Reg. at 46,698-99.
30- Id. at 46,699.
306 Id.
307 Id. at 46,736.
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catastrophic coverage is triggered. For the federal government, ei-
ther employer option saves money because it lowers the govern-
ment's reinsurance costs. 30 8
The Proposed Rule also highlighted that the "[i]ntent of the
MMA retiree prescription drug subsidy provisions is to slow the
decline in employer-sponsored retiree insurance."30 9 Overall, CMS
has noted four "key policy objectives" with regard to the employer
subsidy under the MMA: (1) "maximizing the number of retirees
benefiting from the special retiree drug subsidy," (2) "assuring that
plan sponsors contribute to retiree drug coverage at least what
Medicare pays on retirees' behalf," (3) "minimizing administrative
burden while maximizing flexibility for employers and unions," and
(4) "remaining within budget estimates. '310 In furtherance of at least
the first goal, CMS stated that it intends "to make these subsidy pay-
ments as reasonably available to plan sponsors as possible. '31' Re-
flecting this approach, the Proposed Rule not only discussed in
detail a range of alternative approaches under consideration, but
also solicited comments on all aspects of Medicare Part D
implementation.
B. January 2005 Final Rule
In late January 2005, after receiving 7,696 individual pieces of
correspondence with comments on the Proposed Rule, CMS issued
a Final Rule governing implementation of Medicare Part D.312 The
Rule covers 391 pages, of which only sixty pages contain actual reg-
ulations. The remaining pages contain CMS' extensive commen-
tary, addressing the issues received during the comment period.
Concurrent with publication of the Final Rule on Part D, CMS also
issued its Final Rule on Medicare Advantage, a relatively minor 155
pages reflecting more than 1,000 comments received following pub-
lication of that Proposed Rule. 313
The Part D Final Rule begins its discussion of employer-spon-
sored retiree prescription drug coverage with two positive state-
38 Id.
309 Medicare Program; Medicare Prescription Drug Benefit, 69 Fed. Reg. at 46,737.
310 HAMELBURG, supra note 279.
311 Medicare Program; Medicare Prescription Drug Benefit, 69 Fed. Reg. 46,632, 46,737 (Aug.
3, 2004) (to be codified at 42 C.F.R. pts. 403, 411, 417, and 423).
312 Medicare Program; Medicare Prescription Drug Benefit, 70 Fed. Reg. 4194, 4198 (Jan. 28,
2005) (to be codified at 42 C.F.R. pt. 423).
313 Medicare Program; Establishment of the Medicare Advantage Program, 70 Fed. Reg. 4588
(Jan. 28, 2005) (to be codified at 42 C.F.R. pts. 417 and 422).
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ments: (1) that the overall impact of employer coverage and
Medicare Part D "will result in combined aggregate payments by
employers/unions and Medicare for drug coverage on behalf of re-
tirees that are significantly greater than they otherwise would have
been without the enactment of the MMA" and (2) that Medicare Part
D and the employer subsidy "represent a particularly important
strengthening of health care coverage for future Medicare-eligible
retirees," the latter especially important in light of the "erosion in
the availability and generosity of employment-based retiree cover-
age for future Medicare beneficiaries that has already been taking
place. '314 From that optimistic starting point, the Final Rule then
discusses various aspects of the Part D subsidy for employer-spon-
sored retiree plans and other options available to employers. Un-
derlying the discussion are the same four basic policy guidelines
stated in the Proposed Rule, with some refinements in the first two
guidelines: (1) "maximizing the number of Medicare-eligible retirees
with high quality employer or union-provided retiree drug cover-
age, and maximizing the generosity of their coverage," and (2)
"avoiding financial windfalls in the retiree drug subsidy program
by ensuring that plan sponsors contribute at least as much to retiree
drug coverage as Medicare pays them as a subsidy." 15
CMS lays out a more refined vision of employer options in the
Final Rule than it had included in the Proposed Rule, presumably
reflecting the effect of considerable outside input. In the Final Rule,
CMS divides the employer options into two fundamentally different
approaches. The first approach-to continue an employer's existing
retiree prescription drug plan and apply for the Medicare Part D
subsidy-maintains the status quo for retirees, but gives employers
a financial boost.316 The second approach-to redesign an em-
ployer's retiree coverage to coordinate with an approved new Medi-
care Part D prescription drug plan-throws the status quo to the
wind and instead fully embraces the new Medicare program.317 The
first approach is relatively straightforward for employers whose ex-
isting plans provide coverage that is at least actuarially equivalent
to the standard Medicare Part D package. The second approach,
314 Medicare Program; Medicare Prescription Drug Benefit, 70 Fed. Reg. at 4476.
3
15 Id.
316 Id.
317 1d. at 4477.
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however, allows a variety of alternative implementation
strategies.318
CMS characterizes the second approach (coordinating with a
Medicare Part D prescription drug plan) as a way for employers
currently sponsoring retiree prescription drug plans to "provide ad-
ditional drug coverage" by encouraging retirees to enroll in a new
Medicare Part D plan and then by providing coverage "over and
above the standard Part D benefit that maintains or exceeds the gen-
erosity of their current benefit designs."319 According to the Final
Rule, an employer may provide the enhanced coverage by (1) con-
tracting with a third-party Part D prescription drug plan to provide
"enhanced benefits" to the employer's retirees, (2) arranging for a
third-party prescription drug plan provider (or Medicare Advan-
tage organization) through a CMS waiver to "offer a customized
plan that is exclusive to the employer['s] . . . retirees," (3) directly
offering a Part D prescription drug plan "that offers an enhanced
benefit" to their retirees by becoming an approved Part D prescrip-
tion drug plan sponsor, or (4) offering separate supplemental, wrap-
around drug coverage that coordinates with a Part D plan.320 In ad-
dition, CMS notes that employers may also pay all or part of Medi-
care Part D premiums for their retirees. 321 Despite what appear to
be close similarities between the various options, the Final Rule pro-
vides relatively little elaboration as to how the details of the differ-
ent arrangements might work.
The Final Rule does, however, identify a number of factors that
CMS believes will affect employers' choices among the various op-
tions. First, CMS expects whether an employer is subject to federal
income tax to significantly impact the value of the Part D employer
subsidy for that employer. 322 As noted previously, CMS estimates
that the subsidy will be worth on average $668 per retiree without
taking into account the tax-free nature of the subsidy. 323 For a taxa-
ble employer, the nature of the subsidy increases its value to about
$891 per retiree for a corporation with a marginal tax rate of 25%
and about $1,028 per retiree for a corporation with a 35% marginal
tax rate. 324 Second, CMS expects whether or not an employer cur-
318 Id.
319 Medicare Program; Medicare Prescription Drug Benefit, 70 Fed. Reg. at 4477.
320 Id.
321 Id.
322 Id. at 4478.
323 Id.
324 Medicare Program; Medicare Prescription Drug Benefit, 70 Fed. Reg. at 4478.
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rently uses a supplemental or wrap-around approach with Medi-
care Parts A and B and retiree health coverage to affect the
employer's choice.3 25 CMS believes that employers who currently
use a wrap-around approach with other parts of Medicare may pre-
fer that approach with Part D.326 A third factor from CMS' perspec-
tive is whether an employer's existing retiree prescription drug
package reaches the actuarially equivalent threshold to qualify for
the Part D employer subsidy.327 An employer whose existing pack-
age was almost, but not quite, actuarially equivalent might choose
to increase benefits just enough to qualify for the subsidy or instead
switch to a wrap-around approach to maintain the same level of
employer contribution (and, CMS hopes, provide a more generous
overall benefit for retirees when the combined Part D and employer
wrap-around coverage is taken into account).328
The Final Rule also acknowledges a number of additional fac-
tors raised by commentators responding to the Proposed Rule. 329
These include: "the timeframe of CMS regulation and guidance; the
degree of flexibility in the retiree drug subsidy program (for exam-
ple, relating to the actuarial equivalence methodology, application
process, plan sponsor and qualifying covered retiree definitions,
payment methodology and frequency, and subsidy payment alloca-
tion requirements); the amount of flexibility in the waiver process
for employer-sponsored [prescription drug plans and Medicare Ad-
vantage prescription drug plans]; the financial incentives and de-
gree of administrative burden associated with the various options;
the timely availability of feasible PDP and wrap-around options in
the market; and employers and unions' own internal timeframes
and processes required to make benefit design changes."330 Still ad-
ditional concerns raised either by commentators or CMS include the
cost of the actuarial attestation required to qualify for the subsidy,331
the claims tracking requirements involved in ongoing qualification
for the subsidy,332 a Governmental Accounting Standards Board rule
issued in 2004 that requires similar accounting by state and local
323 Id.
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governments to what FAS 106 requires from private employers,333
and long-term economic and demographic trends (such as rising
health care costs and increasing retiree populations as compared to
active populations).334
Both the number and the range of factors that are expected to
affect employer choices with respect to future retiree prescription
drug coverage lead to CMS' observation in the Final Rule that "most
employers and unions have not yet decided how they will respond
to the options that are available to them under the Medicare drug
benefit and retiree drug subsidy. '335 CMS acknowledges that, while
"early evidence suggests" that current retirees are likely to continue
to receive some level of employer-provided prescription drug bene-
fit, in the long run this may change.336 This may prove particularly
true as drug costs continue to increase, as employers who have
adopted caps on retiree health costs begin to approach those caps,
and as the value of the Medicare Part D standard prescription drug
package begins to equal or exceed the value of employer plans.337
The Final Rule also addresses a number of practical implemen-
tation issues with respect to which CMS had requested comment in
the Proposed Rule. First, with respect to the determination of
whether an employer's retiree prescription drug coverage is at least
actuarially equivalent to the Part D standard benefit package (and
thus qualifies for the Part D employer subsidy), CMS considered
several alternative approaches to determining actuarial equiva-
lence.338 The primary difference between the approaches was the
degree to which the actuarial valuation would take into account re-
tiree contributions toward the cost of coverage.339 In the Final Rule,
CMS adopts a two-part actuarial equivalence test. First, an em-
ployer must pass a total or "gross" value test that evaluates whether
the total value of the employer's benefit at least equals the value of
the standard Medicare Part D benefit.34° Then, the employer must
satisfy a "net" value test that again evaluates whether the total value
of the employer's benefit at least equals the value of the standard
Medicare Part D benefit, but then also takes into account the spon-
333 Id. at 4480.
334 Medicare Program; Medicare Prescription Drug Benefit, 70 Fed. Reg. at 4481-82.
335 Id. at 4480.
336 Id. at 4481.
337 Id.
338 Medicare Program; Medicare Prescription Drug Benefit, 69 Fed. Reg. at 46,741.
339 See id.
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sor's contribution toward financing the employer benefit.34 1 The
"net" value test also considers the effect of an employer plan that
supplements Medicare Part D coverage. 342 From CMS' perspective,
the combined tests "minimize windfalls and present a good balance
for both beneficiaries and plan sponsors. 343
In addition to the actuarial equivalence issues, the Final Rule
also specifies exactly what must be included in an employer's appli-
cation to CMS for the employer Part D subsidy, including a signifi-
cant amount of participant-specific information (such as full names,
dates of birth, Social Security numbers, and relationship to the re-
tired employee).344 An employer must provide this information
each year no later than ninety days before the start of the next plan
year (unless an extension request has been filed with and approved
by CMS).345 This will require employers to complete all plan design
changes well in advance of the annual deadline, and possibly to
complete open enrollment by that date as well. This could signifi-
cantly change timing of the planning process for most employers.
Employers must also provide claims-related data each year, which
may require end-of-year reconciliations.346 Although insured ar-
rangements can be eligible for the subsidy, participating will require
maintenance and provision of some employer-level data. 347
C. Other CMS Guidance
In meetings with industry benefit experts, CMS in early and
mid-2005 again outlined the same basic employer options as de-
scribed in the Final Rule, then discussed reasons why an employer
might choose one option over another.34s From CMS' perspective,
employers may choose to retain current prescription drug plans for
retirees and pursue the subsidy for a variety of reasons. Such a de-
cision minimizes change, avoids the "lead time" required to rede-
sign and roll-out a different program, avoids possible restrictions
under existing contracts or collective bargaining agreements, and
341 Id.
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gives an employer time to "see how the market evolves before com-
mitting to change." 349
On the other hand, CMS noted that some employers may wish
to move toward supplemental (or wrap-around) coverage, espe-
cially those who will not enjoy the tax benefits of the subsidy (be-
cause they are tax-exempt or a governmental plan), or those who
simply will not qualify for the subsidy because their plans fail to
reach the actuarial equivalence threshold.350 Supplemental coverage
can fill in the gaps where Medicare Part D does not provide cover-
age, which helps a retiree, and an employer benefits from the signif-
icant subsidy provided by the federal government through the costs
covered by Medicare Part D.351 CMS also observed that adopting a
wrap-around coverage approach may also be easy for both employ-
ers and retirees to understand because it follows the model already
in place for many employer-sponsored retiree plans that coordinate
with traditional Medicare benefits.352 Adopting a stand-alone plan
also avoids issues of availability of national prescription drug plans
or Medicare Advantage prescription drug plans, a key concern for
large employers who may have retirees scattered across the United
States.353 However, CMS stressed that supplemental coverage can-
not count toward a beneficiary's meeting the $3,600 out-of-pocket
spending limit before Part D catastrophic coverage becomes effec-
tive,3m which may limit the attractiveness of this option for some
employers. Additional issues include coordination of benefits chal-
lenges for an employer who decides to implement a stand-alone
supplemental plan.355 CMS indicated that it intends to assist em-
ployers with these challenges and is working "to facilitate effective
coordination of benefits."356
For some employers whose existing retiree prescription drug
plans either fail to qualify for the Part D subsidy, or who will not
realize any tax benefits from the subsidy, CMS believes that the
waiver approach (i.e., becoming sponsor of an approved Medicare
Part D prescription drug plan customized through a waiver for an
individual employer's retiree population) may be more appealing
349 Id.
350 Id.
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than adopting a stand-alone supplemental plan because certain em-
ployers may prefer the "opportunity to provide [a] more integrated
approach to drug and other health coverage . . . and avoid [the]
operational challenges of stand-alone coordination of benefits. 3 57
For employers who choose to become prescription drug plan
or Medicare Advantage prescription drug plan sponsors them-
selves, and then provide customized coverage directly pursuant to a
CMS waiver, CMS has indicated that its review of waiver applica-
tions will consider three goals: (1) "providing sponsors with maxi-
mum flexibility and minimum administrative burden so they keep
offering-and retirees can retain-high quality retiree prescription
drug coverage," (2) budget issues, and (3) "providing appropriate
protections Medicare beneficiaries may expect from Part D bene-
fits. '358 CMS has also independently issued a number of classes of
waivers (in three separate pieces of guidance dated February 11,
March 9, and April 6, all of 2005) that will automatically apply to
direct contracts between employers and CMS, as well as waivers
that will apply to employer plans that purchase benefits from other
Part D plan sponsors.359 The waivers do not require individual ap-
plications to CMS by employers.36°
Key waivers include (1) waiver of certain management and op-
erational requirements under the MMA 361 for employers subject to
ERISA fiduciary requirements or similar state or federal law stan-
dards; 362 (2) waiver of the actuarial equivalence test for alternative
coverage for plans offered "exclusively to employer or union retir-
ees;' '363 (3) waiver of the state licensing requirement for an employer
applying to become a prescription drug plan sponsor "solely for
purposes of providing prescription drug coverage to its retirees;" 364
357 Id.
358 Id.
359 CMS, ADDITIONAL PART D WAIVER GUIDANCE FOR EMPLOYER/UNION RETIREE COVERAGE
(Mar. 9, 2005), http://www.cms.hhs.gov/medicarereform/pdbma/EmployerWaiver
Guidance2.pdf (last visited Feb. 25, 2006) [hereinafter MARCH WAIVER GUIDANCE].
360 Id.
361 Id.
362 Id. The waiver is intended to reflect the existence of other statutory oversight requirements
and to "avoid imposing additional (and potentially conflicting) government oversight that
may hinder employers and unions from considering direct Part D contracts with CMS
.... 1 d.
363 Id.
364 CMS, PART D WAIVER GUIDANCE FOR EMPLOYER/UNION RETIREE COVERAGE (Feb. 11, 2005),
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(4) waiver of certain pharmacy access requirements for employer
plans and plans contracting directly with employer plans, subject to
an attestation to CMS that "the plan's networks are sufficient to
meet the needs of its retiree population, including situations involv-
ing emergency access,"'36 (5) waiver of Part D disclosure require-
ments for beneficiary communications and marketing materials,
including requirements for prior CMS approval, in light of em-
ployer plan disclosure requirements under ERISA and other laws, 366
(6) waiver of certain Part D cost reporting requirements (which
mandate reporting of cost of operations and financial statements to
CMS, enrollees, and the public at large) as long as "information re-
garding such arrangements [is] reported to enrollees and to the gen-
eral public to the extent required by other law (including ERISA or
securities laws) or by contract," 367 (7) waiver of Part D's prohibition
against state or local government sponsorship of Part D prescription
drug plans for governmental entities that wish to sponsor a Part D
prescription drug plan for their retirees,368 and (8) waiver of a Part D
requirement that a Part D prescription drug plan accept any Medi-
care beneficiary who lives within the plan's service area, but only
beneficiaries who live within that area.369 The latter waiver allows
an employer-sponsored Part D prescription drug plan to cover only
the employer's retirees, without regard to where they may reside.370
Since April of 2005, CMS has continued to issue guidance, or-
ganize conference calls, and generally assist employers in every way
possible to encourage continuation of existing retiree prescription
employer to meet certain solvency and other standards. CMS has also provided for a
waiver, on a case-by-case basis, of its own standards for an employer plan that can demon-
strate "that its fiscal soundness is commensurate with its financial risk and that through
other means the entity can assure that claims for benefits paid for by CMS and benefi-
ciaries will be covered." MARCH WAIVER GUIDANCE, supra note 359.
365 FEBRUARY WAIVER GUIDANCE, supra note 364. Medicare Part D generally prohibits a pre-
scription drug plan from limiting coverage to mail order prescription drugs and requires a
plan to offer "broad networks of retail pharmacies to provide convenient access to benefi-
ciaries," but CMS recognized that the pharmacy access requirements applicable to pre-
scription drug plan sponsors in general may not be needed for employer plans, which
already have an "interest in ensuring their retirees have adequate pharmacy access" and
"may have only . . . small numbers of retirees concentrated in a local area within a large
region." Id.
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drug plans.371 For example, CMS argued that the subsidy has
"highly flexible rules that permit employers.., to continue provid-
ing drug coverage to their Medicare-eligible retirees at a lower cost
while retaining their current plan designs."372 CMS also outlined
what it called a "streamlined process" for employers to qualify for
and receive the drug subsidy.373 CMS has also established a sepa-
rate website specifically for employers interested in the retiree drug
subsidy.374
VI. EMPLOYER REACTIONS
A February 2005 report by the Government Accountability Of-
fice (GAO) determined that many employers who currently offer
retiree prescription drug coverage had yet to reach final decisions
about what they will do following the January 2006 implementation
of Medicare Part D.375 Most, however, expected to adopt the Part D
employer subsidy approach at least for 2006.376 Employers who had
previously established caps on retiree health liability generally ex-
pected to adopt some level of wrap-around coverage, and most em-
ployers planned to coordinate in some way with a Medicare Part D
plan rather than to develop their own comprehensive plan.377 Over-
all, employers did not immediately expect to reduce their own re-
tiree drug coverage, but believed that continuing health care cost
increases could result in such reductions in the future.378 There was
no evidence to suggest that any employer not currently offering re-
tiree prescription drug coverage would become tempted to imple-
ment such coverage as a result of Medicare Part D.379
371 See generally CMS, PRESCRIPTION DRUG PLANS, http://www.cms.hhs.gov/pdps/ (last vis-
ited Feb. 25, 2006). See also CMS, TRAINING & USER GROUP INFORMATION, http://www.
cms.hhs.gov/pdps/Trning-UsrGrpnfo.asp (last visited Feb. 25, 2006).
372 CMS, THE RETIREE DRUG SUBSIDY: WHY EMPLOYERS AND UNION PLAN SPONSORS SHOULD
CONSIDER IT, (Apr. 6, 2005), http://www.cms.hhs.gov/medicarereform/pdbma/Retiree
DrugSubsidy4Emp04-06-05.pdf (last visited Feb. 25, 2006).
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The GAO findings match various industry reports on em-
ployer plans. For example, a 2005 survey by Deloitte Consulting
found that 90% of employers currently offering retiree prescription
drug coverage intended to continue some level of coverage follow-
ing passage of Medicare Part D, and about 55% of those who in-
tended to continue coverage either planned to apply for the
Medicare Part D employer subsidy, or were "leaning" in that direc-
tion.380 Of the employers surveyed, 19% were either "leaning to" or
had decided on wrap-around coverage.381 Key factors for employ-
ers leaning toward applying for the Part D employer subsidy were
the effect of their choice on their financial statements and the eligi-
bility of the existing retiree plan for the subsidy, closely followed by
the challenges of "communicating plan design changes to retir-
ees. '382 For employers leaning toward adopting some form of wrap-
around coverage, the effect on the employers' financial statements
remained a primary concern, but was closely followed by concerns
over administrative issues.383
Another 2005 report, this one by Chicago Consulting Actua-
ries, anticipated that most employers will choose the employer sub-
sidy for 2006 "because it is the simplest to implement and involves
the least change."3s4 On the other hand, the report noted, the ad-
ministrative hurdles to applying for the subsidy-such as the actua-
rial attestation, data collection and reporting requirements, and
timing issues-may reduce the attractiveness of this option for some
employers. 385 For large employers with significant Medicare-eligi-
ble populations currently covered by employer-sponsored retiree
prescription drug coverage, the report suggested that becoming a
Part D prescription drug plan sponsor may be financially attractive,
despite the considerable time and effort that will be involved in im-
plementing such a decision.3s6 Employers who are attracted to this
approach, but do not want to accept the administrative responsibili-
0 DELOTTE CONSULTING, EMPLOYER RESPONSE TO MEDICARE PART D PRESCRIPTION DRUGS-
2005 SURVEY, http:/ /www.deloitte.com/dtt/cda/doc/content/ushumancapitamedi
caresurvey.pdf (last visited Feb. 25, 2006).
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ties, may decide to contract with third-party Part D prescription
drug plan sponsors.387 The report noted, however, that there re-
mains considerable uncertainty as to the mechanics of such arrange-
ments, and that the availability of such arrangements in the market
is still limited, prompting many employers to take a "wait and see"
approach to this option.3M8 The report concluded what CMS and
many other reports tend to leave unsaid: that it may be easier and
more appealing for many employers to eliminate any form of direct
retiree drug coverage and simply provide financial assistance to re-
tirees to help cover Medicare Part D premiums. 38 9
VII. EMPLOYER ALTERNATIVES AFTER THE MMA
For Medicare-eligible retirees, virtually all the factors that
might cause an employer to make a choice in one direction or an-
other with regard to retiree prescription drug coverage changed as a
result of the MMA.390 Just as the initial passage of Medicare in the
1960s suggested that American society could set aside its general
preference for private solutions when the social need (at the time
Medicare passed, the need was for a general health care safety net
for the elderly) became sufficiently pressing, so too does the passage
of the MMA, with the creation of Medicare Part D, suggest that pub-
lic concern over prescription drug costs for the elderly has finally
trumped an entrenched bias against federal government interven-
tion. The existence of Medicare Part D also removes much of the
teeth from the most powerful public policy argument previously in
favor of continued employer retiree prescription drug coverage-
that no sufficient alternative existed for the vast majority of retir-
ees.391 Remembering the general assumption that access to care (in-
cluding prescription drug coverage) is a preferred social goal in the
United States, 392 and in the absence of any government-funded gen-
erally available alternative, employer-sponsored retiree prescription
drug coverage in the pre-MMA days met a critical need.393 With
387 Id.
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389 CHICAGO CONSULTING AcTuARiEs, supra note 384.
390 Because Medicare Part D provides prescription drug coverage only for Medicare-eligible
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391 See discussion supra Section II.F.
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Medicare Part D in place, an arguably better and more widely avail-
able alternative exists.
The presence of the Medicare Part D prescription drug safety
net also undercuts the financial "common good" argument that em-
ployer retiree prescription drug coverage should be maintained be-
cause, in the absence of a good alternative in the pre-MMA days, it
was by far the best way to encourage medication compliance by re-
tirees-and to avoid expensive health complications that result from
medication noncompliance and that eventually increase society's
costs through higher Medicare expenses (or government-funded
charity care for those not eligible for Medicare). 394 On the other
hand, a financial "common good" argument may still be made in
favor of maintaining employer retiree drug plans to reduce the bur-
den on Medicare. Medicare costs threaten to overwhelm the federal
budget.395 The exact cost of adding prescription drug coverage to
Medicare has provoked ongoing debate, but no one doubts that the
added expense is massive. 396 In fact, recent government budget
figures project the cost for the drug benefit alone to be $1.2 trillion
over the next decade. 397 Those numbers assume some level of con-
tinuing employer retiree prescription drug coverage. If employers
were to significantly reduce or altogether stop their contributions
toward retiree prescription drug coverage, the cost of the Medicare
Part D program would necessarily increase. For example, assuming
retirees do not elect Part D, an employer providing a retiree pre-
scription drug plan with benefits that are actuarially equivalent to
the standard Medicare Part D package will save the federal govern-
ment the difference between the cost of that coverage and the cost of
the 28% Part D subsidy. Given that one in three Medicare benefi-
ciaries currently has some level of employer prescription drug cov-
erage,39 8 and given the pervasive sense that many current employer
plans provide coverage that is at least actuarially equivalent to
394 Id.
395 See, e.g., Tom Abate, Medicare Faces Cost Crisis; Multitrillion-dollar Deficits Loom Over Federal
Programs, S.F. CHRON., Nov. 7, 2004, at B1, available at http://www.sfgate.com/cgi-bin/
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Medicare Part D,399 any significant percentage of those beneficiaries
moving from employer coverage to Part D could negatively impact
the financial position of the Medicare program. In the long run,
skyrocketing Medicare costs will result in either benefit cutbacks,
increased taxes, or both.40 While such long-term risks may be
somewhat remote for an individual employer to contemplate, their
presence nonetheless advocates for maintaining employer plans.
When considering the financial benefit for Medicare of contin-
uing employer retiree drug coverage, such coverage cannot be com-
pared directly with general employer health insurance for
Medicare-eligible retirees, at least not in the current environment.
Other than prescription drug coverage, the vast majority of em-
ployer retiree health insurance for Medicare-eligible individuals
currently wraps around or otherwise supplements Medicare.4°1 As
a result, the federal government generally carries the overwhelming
majority of the financial burden for health care for such individuals
without regard to whether they have employer-provided retiree
health insurance or not. The same will not necessarily be the case
with Medicare Part D and employer retiree prescription drug cover-
age because, at present, employer plans are an alternative, not a
complement, to Part D. As long as employer retiree prescription
drug plans remain an alternative, the government continues to es-
cape a significant financial responsibility.
Taking a different perspective, one might suggest that shifting
all prescription drug coverage to the government would lead to a
more equitable sharing of costs across the tax base. Because large
employers tend to be the only ones who still provide retiree health
insurance with prescription drug coverage as a standard benefit,
such employers disproportionately shoulder the burden of that cov-
erage. If all retiree prescription drug coverage falls on Medicare,
assuming that taxes eventually increase to balance the budget (as
opposed to cutting back Medicare, which seems unlikely), the tax
burden will be spread across the entire tax base. On some level, this
will cause everyone, corporations and individuals alike, to share in
the cost of prescription drug coverage for the elderly. On a practical
399 See, e.g., MELLON FIN. CORP., CMS FINAL MEDICARE REGULATIONS PROVIDE GUIDANCE ON
Ti-E EMPLOYER SUBSIDY (Jan. 28, 2005), available at http://www.mellon.com/hris/pdf/fyi_
01_28_05.pdf (last visited Feb. 25, 2006).
4w Derek Hunter, Medicare Drug Cost Estimates: What Congress Knows Now, BACKGROUNDER,
Apr. 28, 2005, at 7, available at http://www.heritage.org/Research/HealthCare/bg849.
cfm (last visited Feb. 25, 2006).
401 McDEvrrr ET AL., supra note 69, at 3.
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level, however, any argument that relies on an assumption of in-
creased taxes rarely fares well in the United States, and many Amer-
icans may not feel overly sympathetic toward large corporations.
Another argument in favor of shifting retiree prescription drug
coverage entirely to the public sector and away from employment-
based coverage also rests on fairly abstract fairness principles. Re-
tiree prescription drug coverage, when provided in the private sec-
tor, can be arbitrary in design.4°2 As noted before, because
employers operate with little regulatory oversight of benefit design
decisions, they enjoy almost unfettered flexibility in making cover-
age determinations. 4° 3 This leeway may encourage creativity, par-
ticularly in cost control strategies, and allow positive choices that
are well-tailored to the needs of a specific employer's population;
but it may also lead to seemingly unfair coverage decisions when
one employer's coverage is compared to another employer's cover-
age. Moving coverage into the public sector means that everyone
receives basically the same benefit. This may appeal to those who
desire equality of treatment above all else.
Many of the other factors-such as market competitiveness,
employee relations, employer altruism, or paternalism-that might
previously have caused an employer to continue offering such cov-
erage may also change as a result of Part D's existence. When no
other reasonably attractive alternative existed, employees who did
value retiree benefits might have been swayed in employment deci-
sions by the presence of retiree prescription drug coverage.404 With
Medicare Part D in place, an employee may perceive the value of
retiree prescription drug benefits as less relevant than other com-
pensation. This may be true even if, as many industry observers be-
lieve, current employer-provided coverage tends to be more
generous than Part D.405 On the employer side, Part D may relieve
an altruistic employer of a sense of moral obligation to preserve re-
tiree health by maintaining retiree prescription drug coverage. Part
D may instead free that employer to make financial decisions with-
out the concern of leaving retirees in the lurch. Even where an em-
ployer has a contractual obligation to maintain retiree prescription
drug coverage, exactly what that coverage looks like may change
given the existence of Part D.
402 See text accompanying supra notes 53-55.
403 See discussion of ERISA's preemptive impact, supra note 49.
404 See discussion supra Section Il.F.
405 See, e.g., Milt Freudenheim & Robert Pear, Retirees Must Weigh Company Coverage Against
Medicare Plan, N.Y. TIMs, Nov. 4, 2005, at C1.
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In 2006, most employers may be expected to make few if any
changes, but apply for the Part D subsidy assuming their retiree
plans qualify.4 6 This option will appeal to retirees because it main-
tains the status quo for them. Presuming the retirees already under-
stand their coverage, they can simply continue as they have before.
The option holds some of the same appeal for employers. Imple-
menting major employee benefit plan design changes requires long-
term planning, dedicated personnel, and resources. Such changes,
especially for larger employers, do not happen quickly or easily
even when all factors lie within an employer's control. As dis-
cussed in more detail below, many Part D employer options remain
filled with questions and uncertainties. Employers tend to prefer
answers and some degree of certainty, especially before committing
time and money to change. For such employers, staying with their
existing retiree plans in 2006 avoids hidden pitfalls and gives them
an additional year to consider alternatives before committing to a
major plan redesign.
On the other hand, the employer subsidy option does have its
own issues. As a preliminary matter, some plans may not actually
qualify as actuarially equivalent even with CMS' efforts in the Final
Rule to develop as accommodating a standard as possible.40 7 For
plans that do not meet the standard, decisions should not be post-
poned for another year. In such cases, an employer should ascertain
whether the value of the subsidy would be sufficient to justify the
cost of improving the employer's plan to the level necessary to qual-
ify for the subsidy. If not, the employer may want to consider one
of the other options and evaluate whether converting the em-
ployer's current plan into some kind of supplemental coverage to
Part D could provide retirees with a greater level of coverage at the
same (or lower) cost to the employer.
Even if an employer's existing plan is actuarially equivalent to
the standard Part D basic package and qualifies for the employer
subsidy, the subsidy may be less valuable to a tax-exempt or gov-
ernmental employer who will not enjoy any additional benefit from
the tax-free nature of the subsidy. While such employers should
still apply for the subsidy if their plans qualify and if they do not
want to make any changes for 2006, they may have somewhat more
incentive than taxable employers to go ahead and evaluate other
406 See discussion supra Section VI.
407 Medicare Program; Medicare Prescription Drug Benefit, 69 Fed. Reg. 46,632, 46,737 (Aug.
3, 2004) (to be codified at 42 C.F.R. pts. 403, 411, 417, and 423). See generally discussion
supra Section V.
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options. Taking into account the base 28% subsidy value, if such
employers consider the overall employer cost of retiree drug cover-
age, and evaluate how their employer dollars might be best spent,
they may be able to provide a better drug benefit package for their
retirees with supplemental coverage. Of course, the same logic gen-
erally applies to all employer plan sponsors, but taxable entities will
receive a noticeably greater benefit from the subsidy and may be
more likely to defer consideration of other alternatives as a result.
All employers applying for the subsidy also face considerable
expense and administrative headaches as they hire actuaries and es-
tablish new tracking and reporting processes to meet the require-
ments for the subsidy.4°8 Although CMS' express intent is to
encourage employers to retain existing plans and apply for the sub-
sidy, the recordkeeping and attestation requirements remain daunt-
ing.409 Moreover, employers face complicated employee
communication and coordination issues. As noted above, the sub-
sidy will not be paid to an employer for any retiree who enrolls in
Part D, yet nothing in Part D prevents such dual enrollment in Part
D and an employer plan.410 Facing an avalanche of communications
from every side, many retirees may become confused and enroll in
both without even intending to do so. Tracking and sorting out
these issues will require entirely new practices by employers, for
which there is no current precedent. In addition, for some low-in-
come retirees who qualify for the MMA's low-income assistance,
Part D may be a much better package than anything the employer
can offer.411 Employers may want to provide sufficient communica-
tions materials to these retirees to help them realize that, in fact,
they should enroll in Medicare Part D, not the employer plan. If an
employer fails to do so, the retiree or an irate family member most
likely will realize eventually what the retiree should have done and
may blame the employer. CMS tends to gloss over just how compli-
cated and time-consuming handling such practical issues can be.
Even with the challenges described above, most employers
seem likely to opt for the path of more clarity and relatively less
work for 2006. That choice may not last long, however. Employers
408 See discussion supra Section V.
409 See, e.g., Social Security Act § 1860D-22(a), 42 U.S.C. § 1395w-132(a) (2005).
410 Social Security Act § 1860D-22(a)(6), 42 U.S.C. § 1395w-132(a)(6) (2005).
411 See, e.g., HEwITr Assoc., MEDICARE MODERNIZATION ACT: FINAL REGULATIONS MovE EM-
PLOYERS CLOSER TO FINAL DECISIONS FOR 2006 (Feb. 2005), at 6, available at http://was4.
hewitt.com/hewitt/ resource/legislative-updates / unitedstates/medicare finalregula-
tions-rx.pdf (last visited Feb. 25, 2006); see also discussion supra Section II.E.
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have been adding cost control measures to their retiree prescription
drug plans for years. In 2001, for example, 72% of all employers
with at least 200 employees and some form of retiree health plan
expected to implement some form of cost-control measures in the
next two years.412 Such measures may include techniques that limit
the number of covered retirees, such as increasing service require-
ments for eligibility or simply eliminating eligibility for new hires,
which does not affect coverage itself, and thus, will not affect quali-
fying for the subsidy. However, cost control measures may also in-
clude techniques such as increasing premiums, deductibles, co-
insurance percentages, co-payments and out-of-pocket expense lim-
its. Because any measure that shifts costs to employees necessarily
lowers the employer's contribution to financing the benefit, and be-
cause an employer's cost is part of the actuarial equivalence deter-
mination,413 such cost control measures will impact the
determination of actuarial equivalence to the standard Part D pack-
age. As prescription drug costs and health care expenses in general
continue to rise, employers will no doubt continue to seek ways to
limit their exposure. They may be too busy qualifying for the sub-
sidy in 2006 to devote much attention to traditional cost control
measures, but in following years they may find their analyses al-
tered by a desire to continue qualifying for the Part D subsidy. Be-
cause certain cost control measures will impact eligibility for the
subsidy, those may become less favored techniques.
Instead, employers may find it preferable to continue to in-
crease service requirements or to eliminate retiree health insurance
for additional groups of future retirees so that the existing coverage
remains unchanged and eligible for the subsidy for covered retirees.
While these tactics protect current retirees and may be more palat-
able than an employer's sudden termination of an ongoing plan,
constantly increasing service requirements or otherwise limiting eli-
gibility for future retirees will eventually eliminate most employer
retiree coverage as existing retirees die and few if any new retirees
enter the plans. By 2001, many employers had already limited re-
tiree health insurance to employees with at least ten to fifteen years
of service who retired on or after age fifty-five414 even though most
412 KAISER/HRET 2000/2001 SuRvEy, supra note 79, at fig. 11; See also discussion supra Section
ILE.
413 See, e.g., HAMELBURG, supra note 279.
414 Future of Retiree Health Benefits, supra note 36, at 6.
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younger workers today do not anticipate remaining employed with
any single employer for such long periods of time.415
For employers who take the Part D subsidy in 2006 and do not
raise eligibility requirements or otherwise pursue cost control mea-
sures that operate as a back-door way of terminating retiree cover-
age, some cost control measures may still be needed.
Unfortunately, most of these measures, which in some way tend to
increase retiree cost-sharing obligations, will impact the actuarial
valuation of the retiree plan's coverage.416 For plans that currently
provide coverage that exceeds the actuarially equivalent value of
the Part D standard package, it may take some time before increas-
ing retiree cost-sharing brings the value of the employer coverage
down to the level of the Part D standard package. For other plans,
any change could disqualify them for the Part D subsidy. In many
cases, however, employers may not have a choice about imposing
cost-sharing. As discussed earlier, many employers adopted caps
on retiree health insurance costs as a reaction to the introduction of
FAS 106 in the early 1990s. 417 As costs reach the caps, employers
must take steps to avoid exceeding the caps, such as by passing ex-
penses above the caps on to retirees. For these employers, once the
caps are reached, if increased cost-sharing causes their plans to fail
to qualify for the Part D subsidy, they will need to revisit their over-
all approach and consider other Part D options or find themselves in
a much worse financial position. Even for employers who are not
limited by caps on retiree health costs, rising prescription drug costs
most likely will eventually trigger a review as to whether the em-
ployer can better use its retiree health care dollars by supplementing
a Part D plan instead of maintaining its old plan. As an additional
concern, once cost-sharing obligations reach too high a level, they
begin to take coverage out of range for most retirees, much as
though the employer had simply terminated the plan. Long before
this level is reached, Part D coverage may be a better option for
many individuals.
As employers move beyond the comparatively easy solution
for 2006 of maintaining existing coverage and qualifying for the
subsidy if available, the options become far less straightforward. 418
415 See, e.g., Stephanie Armour, Generation Y: They've Arrived at Work with a New Attitude, USA
TODAY, Nov. 8, 2005, available at http://www.usatoday.com/money/workplace/2005-11-
06-gen-yx.htm (last visited Feb. 25, 2006).
416 See HAMELBURG, supra note 279.
41 7 KAISER/HEWrIr" 2004 SURVEY FINDINGS, supra note 89, at 9-11.
418 See discussion supra Section V.
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If an employer remains wedded to its traditional plan design and
wants to maintain a similar structure, it may find the option of be-
coming a Part D prescription drug plan sponsor (or Medicare Ad-
vantage plan sponsor) itself and offering alternative coverage
through a waiver to be the most appealing alternative. As long as
the alternative coverage is at least actuarially equivalent to the stan-
dard package, choosing this option gives an employer the opportu-
nity to continue an integrated, customized program for its retirees.
With the many group waivers already issued by CMS, most of the
MMA requirements that would pose serious procedural problems
for employers have already been eliminated. In addition, CMS ap-
pears committed to continuing along a path of supporting employer
efforts under this option.419 Retirees may also prefer this option be-
cause it avoids confusing coordination issues and because, if an em-
ployer generally follows a similar structure to the employer's
previous plan design, they may find the new plan relatively easy to
comprehend. On the other hand, becoming a Part D prescription
drug plan sponsor still entails a great deal of time, money, and ef-
fort to implement, as well as a significant ongoing administrative
and financial commitment from an employer.420 Once an employer
steps beyond maintaining an existing plan, actually becoming a Part
D prescription drug plan sponsor may be too much work for the
perceived benefit.
In lieu of becoming a Part D prescription drug plan sponsor,
the employer may contract with an existing Part D prescription
drug plan sponsor or Medicare Advantage organization to provide
a customized, alternative Part D prescription drug plan for the em-
ployer's retirees.421 As with the employer's becoming a Part D pre-
scription drug plan sponsor, this option relies on CMS' waiver
authority. For retirees, this option may feel indistinguishable
from the employer's sponsoring the plan itself. From the employer
side, contracting with a third party to provide such customized ben-
efits could accomplish the employer's goals with far less hassle al-
though not necessarily less cost. However, the success of this
approach requires Part D prescription drug plan sponsors and
Medicare Advantage organizations in the marketplace to be willing
to provide such customized packages. Alternatively, an employer
419 Id.
420 Id.
421 Medicare Program; Medicare Prescription Drug Benefit, 70 Fed. Reg. 4194, 4477 (Jan. 28,
2005) (to be codified at 42 C.F.R. pt. 423).
422 See HAMELBURG, supra note 279.
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could contract with a Part D prescription drug plan sponsor or
Medicare Advantage organization who has already developed an
enhanced coverage option that meets the employer's needs. At pre-
sent, however, either concept remains very new and quite possibly
unduly expensive in the absence of market competition. Even if
these options may in the long run attract employers who seek to
provide enhanced or customized, integrated prescription drug cov-
erage, most employers for now are not surprisingly taking a "wait
and see" approach until the market settles.423
The "wait and see" approach may not appeal to employers
whose current coverage does not qualify for the Part D subsidy. For
these employers, their retiree prescription drug dollars may provide
a better benefit for their retirees if used in a supplemental or wrap-
around plan. As a result, coordinating with Medicare Part D as
soon as possible will be a top priority, but one that may be filled
with confusion in Part D's initial year. On the other hand, coordi-
nating benefits with Medicare may be attractive to both employers
and retirees who are already accustomed to coordinating general
health benefits with Medicare Parts A and B. Familiarity with the
general approach may make this option much less intimidating than
it would otherwise be. Still, in an effort to avoid negotiating the
complexities of a new Medicare system, employers may seek to
purchase wrap-around coverage through third-party providers
rather than establishing stand-alone plans. Because the marketplace
has only begun to absorb what Medicare Part D means, employers
may find themselves either forced to wait for options or forced to
accept a provider without having the opportunity to consider alter-
natives. This may still be a better solution than retaining old cover-
age that fails to reach the actuarially equivalent threshold if the
employer can cost effectively offer its retirees more generous cover-
age by combining supplemental coverage with a third-party Medi-
care Part D prescription drug plan.
If an employer provides truly limited retiree coverage, the best
answer may be for the employer to terminate its own plan and, in-
stead, direct its contributions toward covering its retirees' Medicare
Part D premiums. This removes administrative hassles from the
employer and may provide a better level of coverage for the retirees.
Of course, as time passes and Medicare Part D premiums increase,
the employer will be faced with a decision of whether to cap its
premium payments or to absorb the increases.
423 See discussion supra Section VI.
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Employers who do not want to continue retiree prescription
drug coverage or any level of coordination with Medicare Part D,
but still want to assist their retirees in some way, may consider mak-
ing contributions to employee health savings accounts during em-
ployees' working lives. Amounts held in such accounts may be
used to cover beneficiary out-of-pocket costs under Medicare Part
D.424 However, contributions may not be made by Medicare-eligible
beneficiaries, 425 and that makes this an option only for future
retirees.
VIII. CONCLUSION
It is tempting to evaluate the maintenance of any single em-
ployer's prescription drug plan for retirees in a vacuum and to look
at the options for that employer in light solely of that employer's
financial circumstances, competitive positioning, and internal cul-
ture. Those factors, along with a difficult economy with more peo-
ple wanting work than available jobs, may cause many employers to
see continuing prescription drug coverage as unnecessary for retir-
ees who now have coverage available through Medicare. After all,
the balance has been shifting away from retiree health care benefits
in general for much of the past two decades. In addition, expanded
Medicare coverage helps remove much of the pressing need for sup-
plemental employer coverage for Medicare-eligible retirees. On the
other hand, eliminating employer-provided retiree coverage would
shift considerable additional drug costs to a Medicare system al-
ready strained almost to the breaking point. From a public policy
perspective, this hardly seems a desired result.
Fortunately, at least among those employers who still provide
retiree drug coverage, employer intentions currently support what
seems a wise public policy. The real question, however, is what
form employer coverage will take in the future. For 2006, the path
for most employers seems clear, assuming they can qualify for the
Part D employer subsidy and maintain their existing plans. After
that point, which of the various options becomes most attractive to a
specific employer will depend on numerous factors, including that
employer's own cost constraints and culture. Most importantly,
employers should consider what kinds of alternatives the drug plan
marketplace has created for consideration. No one can predict yet
424 Medicare Program; Medicare Prescription Drug Benefit, 70 Fed. Reg., 4242.
4- 26 U.S.C. § 223 (2005).
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what may be best in the future for any given employer, and no sin-
gle solution seems likely to work for all. Unfortunately, unless the
economic environment and prescription drug expense trends im-
prove, financial concerns for individual employers may quickly out-
weigh any broader public policy arguments in favor of continuing
employment-based retiree prescription drug coverage. This reality
may eventually overshadow the promise of Part D prescription
drug coverage.
